{"study_id": 200161, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of Vitamin E in treating NASH, particularly comparing its effects in pediatric versus adult populations.", "results_summary": "Vitamin E showed some efficacy in pediatric NASH but had questionable efficacy in adults with even mild NASH. The abstract does not detail specific outcomes or statistical significance.", "population_specificity": "Pediatric and adult patients with NASH.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:24.126453+00:00"}
{"study_id": 200159, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the relationship between vitamin E and the risk of cervical neoplasia through a meta-analysis of existing studies.", "results_summary": "The study found that higher vitamin E intake and blood levels were inversely associated with the risk of cervical neoplasia, with an odds ratio of 0.58 (95% CI = 0.47-0.72). Subgroup analyses confirmed this relationship across different populations and types of cervical neoplasia.", "population_specificity": "Women, specifically those involved in 15 case-control studies (3,741 cases and 6,328 controls).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:25.090406+00:00"}
{"study_id": 200162, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine if Vitamin E status differed in CFS and FMS patients compared to healthy controls and whether supplementation improved clinical parameters.", "results_summary": "The study found lower circulating Vitamin E levels in patients compared to controls, but this difference disappeared in high-quality studies. No consistent link was found between Vitamin E and clinical improvements.", "population_specificity": "Chronic fatigue syndrome (CFS) and fibromyalgia syndrome (FMS) patients compared to healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:25.593656+00:00"}
{"study_id": 200160, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether gamma tocopherol (\u03b3T) supplementation reduces eosinophilic airway inflammation and acute neutrophilic response to inhaled LPS challenge in volunteers with asthma.", "results_summary": "\u03b3T supplementation reduced pre-LPS challenge sputum eosinophils and mucins, decreased LPS-induced airway neutrophil recruitment, and prevented post-challenge slowing of mucociliary clearance compared to placebo.", "population_specificity": "Fifteen subjects with mild asthma.", "effective_dosage": "1200 mg of \u03b3T daily.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:25.598526+00:00"}
{"study_id": 200158, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of omega-3 fatty acids and vitamin E co-supplementation on metabolic status in patients with fibrocystic breast disease (FBD).", "results_summary": "The study found that co-supplementation significantly improved inflammatory markers, oxidative stress biomarkers, and metabolic profiles, including reduced insulin resistance, triglycerides, and VLDL-cholesterol, and increased HDL-cholesterol and insulin sensitivity.", "population_specificity": "56 female patients with fibrocystic breast disease (FBD).", "effective_dosage": "400 mg vitamin E plus 1000 mg omega-3 fatty acids daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:26.185693+00:00"}
{"study_id": 200163, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers sought to determine whether vitamin E supplementation provides cardiovascular protection specifically in individuals with diabetes and the Hp2-2 genotype.", "results_summary": "The study found that vitamin E supplementation was associated with an approximately 35% reduction in cardiovascular disease (CVD) in individuals with diabetes and the Hp2-2 genotype, mediated in part by improved HDL functionality. However, broader clinical trials failed to show benefit in unselected populations, suggesting a pharmacogenomic interaction.", "population_specificity": "Individuals with diabetes and the Hp2-2 genotype.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:28.959903+00:00"}
{"study_id": 200165, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the impact of targeted education on patient and caregiver knowledge about vitamin supplementation, including Vitamin E, and its effect on serum vitamin levels in cystic fibrosis patients with pancreatic insufficiency.", "results_summary": "The study found that targeted education significantly improved knowledge scores and adherence to vitamin use, with a notable increase in Vitamin E levels reaching the therapeutic range post-education.", "population_specificity": "Patients with cystic fibrosis and pancreatic insufficiency, along with their caregivers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:30.602901+00:00"}
{"study_id": 200164, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "To determine the effects of any level of vitamin E supplementation on the frequency of vitamin E deficiency disorders in people with cystic fibrosis.", "results_summary": "Vitamin E supplementation significantly improved serum vitamin E levels in people with cystic fibrosis, particularly with water-soluble formulations. However, no data were available on primary outcomes like vitamin E deficiency disorders or secondary outcomes like lung function and quality of life.", "population_specificity": "People with cystic fibrosis, including children (aged six months to 14.5 years) and unspecified age groups.", "effective_dosage": "Various formulations and doses (specific amounts not detailed).", "study_duration": "10 days to six months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:30.646145+00:00"}
{"study_id": 200166, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of omega-3 fatty acid supplementation versus Vitamin E (control) on dry eye symptoms in patients undergoing LASIK surgery.", "results_summary": "Vitamin E (control group) showed comparable worsening in ocular surface disease index and tear breakup time to omega-3 supplementation, but had significantly higher conjunctival staining and lower Schirmer scores, indicating less favorable tear secretion outcomes.", "population_specificity": "Patients undergoing LASIK surgery (30 in the control group).", "effective_dosage": "400 mg/d Vitamin E.", "study_duration": "1 week before and 12 weeks after surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:33.348244+00:00"}
{"study_id": 200167, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a Silybin-vitamin E-phospholipids complex could improve work ability and reduce anxiety and depression in chronic hepatitis C patients undergoing Peg-IFN and RBV treatment.", "results_summary": "The study found that the supplement significantly improved work ability and reduced depression and anxiety scores compared to placebo, with notable differences in ALT, AST, and viremia levels over time.", "population_specificity": "Patients with chronic hepatitis C undergoing Peg-IFN and RBV treatment.", "effective_dosage": "Vitamin E 30 mg daily (combined with Silybin 94 mg and phospholipids 194 mg in pills).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:34.246177+00:00"}
{"study_id": 200170, "supplement_id": 1664, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Vitamin E supplementation, alone or combined with whey protein, could improve malnutrition and inflammation scores in hemodialysis patients.", "results_summary": "Vitamin E supplementation alone showed a modest improvement in SGA and MIS scores, though less than the whey protein groups. Combined with whey, it yielded the greatest improvement, with statistically significant results compared to the control.", "population_specificity": "92 hemodialysis patients with malnutrition (SGA score > 7).", "effective_dosage": "600 IU of Vitamin E, 3 times a week.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:34.661639+00:00"}
{"study_id": 200169, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to clarify the potential preventive role of Vitamin E, particularly its isoforms, in asthma development, focusing on lung inflammation, immune development, and effects during pregnancy.", "results_summary": "The study suggests that appropriate fetal exposure to Vitamin E may enhance lifetime resistance to asthma, but results are complex and sometimes contradictory due to variations in Vitamin E isoforms. Further research is needed to clarify these findings.", "population_specificity": "Pregnant women and animal models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:34.923258+00:00"}
{"study_id": 200168, "supplement_id": 1664, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to investigate the acute effects of a single-dose supplementation of gamma and delta tocotrienols (\u03b3\u03b4-T3) on insulinemic, anti-inflammatory, and anti-thrombogenic responses in metabolic syndrome subjects.", "results_summary": "The study found no significant differences in postprandial changes in insulinemic, anti-inflammatory, or anti-thrombogenic markers between \u03b3\u03b4-T3 and placebo treatments, with women showing delayed increases in some markers. Plasma vitamin E levels confirmed absorption of \u03b3\u03b4-T3, but no therapeutic effects were observed.", "population_specificity": "Thirty metabolic syndrome subjects (15 men and 15 women).", "effective_dosage": "Single doses of 200 mg or 400 mg \u03b3\u03b4-T3 emulsions.", "study_duration": "Acute effects measured over 360 minutes (6 hours) post-consumption.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:35.802384+00:00"}
{"study_id": 200171, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether 250 mg of vitamin E supplementation could reduce inflammation and cellular damage caused by exercise under hypoxic conditions simulating high altitude.", "results_summary": "Vitamin E supplementation reduced markers of cell damage (CK-TOTAL, CK-MB, lactate dehydrogenase) and reversed changes in inflammatory cytokines (IL-6, TNF-\u03b1, IL-1ra, IL-10) induced by exercise in hypoxia. It also improved oxygen saturation recovery post-exercise.", "population_specificity": "Nine volunteers performing exercise under normoxic and hypoxic conditions.", "effective_dosage": "250 mg, administered 1 hour before exercise.", "study_duration": "Single dose before each exercise session, with sessions spaced 1 week apart.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:38.077148+00:00"}
{"study_id": 200173, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate whether vitamin E supplementation could protect against cisplatin-induced hearing damage.", "results_summary": "The study found that vitamin E supplementation (400 mg/day) prevented significant hearing loss at certain frequencies compared to placebo, though audiograms and evoked brainstem responses showed no significant changes between groups. The results suggest preliminary neuroprotective effects of vitamin E against cisplatin-induced ototoxicity.", "population_specificity": "Patients with solid malignancies receiving cisplatin chemotherapy.", "effective_dosage": "400 mg per day", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:38.241504+00:00"}
{"study_id": 200172, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether coadministration of omega-3 and vitamin E supplements could enhance SIRT1 and PGC1\u03b1 gene expression and improve oxidative stress and inflammation in CAD patients.", "results_summary": "The study found that vitamin E combined with omega-3 significantly increased SIRT1 and PGC1\u03b1 gene expression and total antioxidant capacity (TAC) in CAD patients, though effects on specific antioxidant enzymes (GPX, SOD) were not statistically significant.", "population_specificity": "60 male coronary artery disease (CAD) patients", "effective_dosage": "400 IU/day of vitamin E", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:39.056289+00:00"}
{"study_id": 200176, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of sublingual GSH, oral GSH, and NAC on oxidative stress markers, including Vitamin E levels in plasma.", "results_summary": "The study found a significant increase in Vitamin E levels in plasma (0.83 \u00b5mol/g; p=0.04) only in the sublingual GSH group after 3 weeks of administration.", "population_specificity": "20 volunteers with metabolic syndrome.", "effective_dosage": "Not specified", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:42.177981+00:00"}
{"study_id": 200174, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether \u03b3-TmT and \u03b4-T forms of vitamin E are more effective than \u03b1-T in preventing prostate cancer in a mouse model.", "results_summary": "The study found that \u03b3-TmT and \u03b4-T significantly inhibited prostate cancer precursor lesions and reduced biomarkers of oxidative stress and inflammation, with \u03b4-T being more effective than \u03b3-T or \u03b1-T.", "population_specificity": "CYP1A-humanized (hCYP1A) mice treated with the dietary carcinogen PhIP.", "effective_dosage": "\u03b3-TmT (0.3% in diet), \u03b4-T, \u03b3-T, or \u03b1-T (0.2% in diet).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:42.410216+00:00"}
{"study_id": 200175, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 10, "quality_score": 75, "study_goal": "The researchers aimed to assess whether Vitamin E, when combined with PUFA supplementation, affected body composition, muscle strength, and physical performance in elderly individuals with decreased muscle mass.", "results_summary": "The study found no statistically significant differences in muscle mass, hand grip strength, or physical performance (TUG test) between groups receiving Vitamin E alone or combined with PUFA. Vitamin E supplementation did not influence the evaluated parameters in elderly individuals with decreased muscle mass.", "population_specificity": "Elderly individuals with decreased muscle mass (low muscle mass or at risk of low muscle mass) based on ALM index.", "effective_dosage": "10 mg/day (PUFA-treated groups) or 11 mg/day (control groups).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:43.700130+00:00"}
{"study_id": 200178, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare antioxidant levels, including vitamin E, between preterm and full-term neonates and assess changes in vitamin E levels from birth to discharge.", "results_summary": "Vitamin E levels were significantly lower in preterm neonates compared to full-term neonates and increased significantly by discharge. Lower vitamin E levels at birth were associated with complications like necrotizing enterocolitis and bronchopulmonary dysplasia.", "population_specificity": "Preterm and full-term neonates (100 in each group).", "effective_dosage": "Not specified", "study_duration": "From birth to discharge (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:43.828017+00:00"}
{"study_id": 200177, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether \u03b1-tocopherol (Vitamin E) supplementation improves HDL function and lipoprotein subfractions in individuals with type 1 diabetes, stratified by haptoglobin (Hp) genotype.", "results_summary": "Vitamin E improved cholesterol efflux in Hp 2-2 carriers but increased lipid peroxides in Hp 1 allele carriers. It also altered lipoprotein subfractions differently by Hp genotype, though no significant interactions were observed.", "population_specificity": "Individuals with type 1 diabetes, categorized by Hp genotype (Hp 1-1, Hp 2-1, Hp 2-2).", "effective_dosage": "Not specified in the abstract.", "study_duration": "8 weeks of supplementation with a 4-week washout.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:45.335410+00:00"}
{"study_id": 200181, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of fat-soluble vitamin supplements, specifically Vitamin E, on fasting flow-mediated vasodilation (FMD) as a marker for cardiovascular disease risk.", "results_summary": "Vitamin E supplementation increased FMD by 2.42% compared to control, with statistical significance (p = 0.015), but no dose-response relationship was evident, and significance depended on one study. The study concluded that the evidence does not unambiguously support using fat-soluble vitamins to improve FMD.", "population_specificity": "303 adults from seven randomized placebo-controlled trials.", "effective_dosage": "300 to 1800 IU per day.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:47.500789+00:00"}
{"study_id": 200183, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "To determine the effects of vitamin E supplementation on the frequency of vitamin E deficiency disorders in people with cystic fibrosis.", "results_summary": "Vitamin E supplementation (both water-soluble and fat-soluble formulations) significantly improved serum vitamin E levels compared to control at one, three, and six months. However, no data were available on primary outcomes like vitamin E deficiency disorders or secondary outcomes like lung function and quality of life.", "population_specificity": "People with cystic fibrosis, including children (aged six months to 14.5 years) and unspecified age groups.", "effective_dosage": "Various formulations and doses were used (specific amounts not detailed).", "study_duration": "Treatment durations ranged from 10 days to six months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:51.458467+00:00"}
{"study_id": 200185, "supplement_id": 1664, "safety_score": "40", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Vitamin E in age-related disease prevention, particularly its effects on bone health and aging.", "results_summary": "The study found that \u03b1-tocopherol, the major form of Vitamin E, stimulates osteoclast fusion and bone resorption, leading to an osteoporosis-like phenotype in rodents. Clinical trials also indicated that Vitamin E supplementation is neutral or harmful in preventing age-related diseases in humans.", "population_specificity": "Rodents and humans (clinical intervention trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:52.056549+00:00"}
{"study_id": 200184, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to describe the management of vitamin E supplementation in a patient with abetalipoproteinemia, focusing on balancing teratogenic risks and maternal-fetal outcomes.", "results_summary": "The study reported successful management of vitamin E deficiency in a patient with abetalipoproteinemia, leading to a healthy pregnancy and child, highlighting the importance of careful supplementation to avoid complications.", "population_specificity": "A patient with abetalipoproteinemia, from puberty through pregnancy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:52.988354+00:00"}
{"study_id": 200186, "supplement_id": 1664, "safety_score": "85", "efficacy_score": 20, "quality_score": 90, "study_goal": "To evaluate the effect of oral vitamin E supplementation on all-cause mortality in apparently healthy people.", "results_summary": "The study found no association between vitamin E supplementation and all-cause mortality, with a relative risk of 1.01 (95% CI 0.97-1.05, p = 0.65). Subgroup analyses also showed no significant effects based on type, dose, duration, or study quality.", "population_specificity": "Apparently healthy adults in developed countries.", "effective_dosage": "23-800 IU/day", "study_duration": "\u2265 6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:53.340333+00:00"}
{"study_id": 200187, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of vitamin E on bone mineral density, fracture risk, and bone metabolism in perimenopausal women.", "results_summary": "Current evidence does not support daily vitamin E use for osteoporosis or hip fracture prevention in perimenopausal women, though some observational studies suggest benefits. Low vitamin E intake was associated with higher hip fracture risk in smokers, and alpha-tocopherol supplementation may negatively affect osteoblastic activity.", "population_specificity": "Perimenopausal women", "effective_dosage": ">6.2mg/day (low intake), quintiles of alpha-tocopherol intake", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:55.645850+00:00"}
{"study_id": 200179, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids with or without vitamin E could influence adiponectin levels and gene expression in patients with coronary artery disease.", "results_summary": "The combination of omega-3 fatty acids and vitamin E significantly improved serum adiponectin and FABP4 levels but did not affect adiponectin gene expression. Omega-3 fatty acids alone did not significantly change adiponectin levels.", "population_specificity": "67 male patients with coronary artery disease.", "effective_dosage": "400 IU/day vitamin E (in combination with 4 g/day omega-3 fatty acids).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:57.492039+00:00"}
{"study_id": 200180, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Vitamin E supplementation, combined with antibiotics, could improve clinical symptoms in girls with acute pyelonephritis.", "results_summary": "Vitamin E supplementation significantly reduced symptoms like fever, urinary frequency, urgency, dribbling, and incontinence compared to antibiotics alone, but did not affect urine culture results or long-term kidney scarring.", "population_specificity": "Girls aged 5-12 years with a first episode of acute pyelonephritis.", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:57.516367+00:00"}
{"study_id": 200188, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether increased vitamin E intake could delay or reverse age-related decline in T cell function and reduce infection risk in the elderly.", "results_summary": "The study found that vitamin E intake above recommended levels may restore impaired T cell function in aging, both directly and indirectly by inhibiting prostaglandin E2. Vitamin E supplementation was associated with enhanced resistance to influenza in aged mice and reduced upper respiratory infections in elderly humans.", "population_specificity": "Elderly human subjects and aged mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:39:59.427674+00:00"}
{"study_id": 200190, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of vitamin E on endothelial function indicators, specifically VEGF levels, in adolescents with metabolic syndrome.", "results_summary": "The study found no significant improvement in serum HDL levels or VEGF reduction with vitamin E supplementation compared to omega-3 or placebo. Omega-3, not vitamin E, showed significant effects on VEGF levels.", "population_specificity": "Adolescents aged 10-18 years with metabolic syndrome.", "effective_dosage": "400 IU/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:00.664273+00:00"}
{"study_id": 200189, "supplement_id": 1664, "safety_score": "80", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review evidence for adverse vitamin E-drug interactions and assess the potential of different vitamin E congeners to alter drug activity.", "results_summary": "The study found no evidence that vitamin E at nutritionally relevant doses causes adverse drug interactions, but high-dose supplements (\u2265300 mg/d) may interact with aspirin, warfarin, tamoxifen, and cyclosporine A. For most drugs, interactions with vitamin E, even at high doses, were unlikely.", "population_specificity": "Not specified (general human population, with focus on supplement users).", "effective_dosage": "Nutritionally relevant doses and high-dose supplements (\u2265300 mg/d).", "study_duration": "Not specified.", "interactions": "High-dose vitamin E may interact with aspirin, warfarin, tamoxifen, and cyclosporine A.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:01.471711+00:00"}
{"study_id": 200191, "supplement_id": 1664, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether vitamin E, alone or combined with other agents, could prevent oxidative stress and reduce all-cause mortality, particularly in relation to cardiovascular disease and cancer.", "results_summary": "The study found no significant correlation between vitamin E intake (alone or combined) and all-cause mortality overall. However, low-dose vitamin E combined with other agents showed a modest reduction in mortality, particularly among individuals without probable or confirmed diseases.", "population_specificity": "Individuals with and without probable or confirmed diseases (general population and subgroups).", "effective_dosage": "Low-dose (<400 IU/d) vitamin E combined with other agents.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:02.219881+00:00"}
{"study_id": 200192, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of tocopherol (Vitamin E) supplementation on exercise performance and oxidative stress by comparing similar studies and conducting a meta-analysis.", "results_summary": "The meta-analysis found that tocopherol supplementation did not significantly protect against exercise-induced lipid peroxidation or muscle damage, likely due to its complex antioxidant nature and low accumulation in muscle tissues.", "population_specificity": "Not specified (studies on exercise performance and oxidative stress, likely involving physically active or athletic individuals).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:03.963238+00:00"}
{"study_id": 200193, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine whether adding Vitamin E supplementation to cholinesterase inhibitors could reduce functional decline or improve cognition in Alzheimer's disease patients.", "results_summary": "Vitamin E supplements reduced the rate of functional decline when combined with cholinesterase inhibitors in one study, but cognition was unaffected in this and other studies. No other nutritional supplements showed convincing benefits in combination with cholinesterase inhibitors.", "population_specificity": "Patients with Alzheimer's disease", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Combined with cholinesterase inhibitors", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:05.007462+00:00"}
{"study_id": 200194, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether vitamin E supplementation has a definitive effect on glycaemic control (HbA1c, fasting glucose, and fasting insulin) in individuals with type 2 diabetes mellitus (T2DM).", "results_summary": "The meta-analysis found no significant overall benefits of vitamin E supplementation on glycaemic control. However, subgroup analyses showed reductions in HbA1c and fasting insulin in patients with low baseline vitamin E status, suggesting potential benefits in specific populations.", "population_specificity": "Individuals with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:05.985203+00:00"}
{"study_id": 200196, "supplement_id": 1664, "safety_score": "95", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether vitamin E supplementation could prevent chemotherapy-induced peripheral neuropathy (CIPN).", "results_summary": "Vitamin E supplementation (300-600 mg/day) significantly reduced the incidence of CIPN, particularly in patients receiving cisplatin, with no reported adverse effects. However, the data were insufficient to conclusively confirm its true value, warranting further large-scale RCTs.", "population_specificity": "Patients undergoing chemotherapy (319 participants across five RCTs).", "effective_dosage": "300-600 mg/day", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:08.082635+00:00"}
{"study_id": 200195, "supplement_id": 1664, "safety_score": "70", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize current evidence on the effects of \u03b1-tocopherol (\u03b1TF) on bone health across cell culture, animal, and human studies to clarify its role.", "results_summary": "The review found mixed effects of \u03b1TF on bone health, with beneficial, harmful, or null outcomes depending on dosage and context. Animal studies generally showed positive effects in osteoporosis models, while high doses were possibly detrimental in normal animals. Human studies mostly indicated a positive relationship between \u03b1TF and bone health, though adverse effects were not observed in humans.", "population_specificity": "Cell culture, animal models (normal and osteoporotic), and human studies.", "effective_dosage": "High-dose \u03b1TF (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "Possible interference with Vitamin K function and blocking of other Vitamin E isomers.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:09.020965+00:00"}
{"study_id": 200197, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of vitamin E supplementation, alone or combined with low-volume exercise, on oxidative stress markers in postmenopausal women.", "results_summary": "Vitamin E supplementation (alone or with exercise) increased biological antioxidant potential and thioredoxin concentrations, but the combination with exercise did not further enhance antioxidant potential. Exercise alone or combined with vitamin E reduced reactive oxygen metabolites.", "population_specificity": "Postmenopausal women", "effective_dosage": "300 mg/d (\u03b1-tocopherol)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:09.772290+00:00"}
{"study_id": 200182, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to systematically review randomized controlled trials (RCTs) to determine the effects of vitamin E supplementation (\u03b1- and \u03b3-tocopherols) on CRP levels.", "results_summary": "Pooled analysis showed a significant reduction in CRP levels (0.62 mg/l) in vitamin E-treated individuals, with heterogeneity across studies. The effect remained significant in all subgroups, though dose, baseline CRP, and intervention duration did not explain the heterogeneity.", "population_specificity": "246 participants in intervention arms and 249 in control arms across 12 RCTs.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:11.072416+00:00"}
{"study_id": 200198, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Vitamin E tocotrienol-rich fraction (TRF) supplementation could improve inflammatory, oxidative, and lipid profiles in chronic hemodialysis patients.", "results_summary": "TRF supplementation did not significantly affect inflammatory or oxidative biomarkers but improved lipid profiles, including reduced triacylglycerols and increased high-density lipoprotein cholesterol, after 12 and 16 weeks compared to placebo.", "population_specificity": "Chronic hemodialysis patients", "effective_dosage": "180 mg tocotrienols and 40 mg tocopherols daily", "study_duration": "16 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:11.340186+00:00"}
{"study_id": 200200, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of Vitamin E, alone or combined with alpha-lipoic acid (ALA), on oxidative stress, inflammation, and malnutrition in hemodialysis patients.", "results_summary": "Vitamin E supplementation, especially when combined with ALA, significantly reduced interleukin-6 levels and improved malnutrition status, though effects on lipid peroxidation and high-sensitivity C-Reactive protein were less pronounced.", "population_specificity": "85 hemodialysis patients", "effective_dosage": "400 IU Vitamin E", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:12.578028+00:00"}
{"study_id": 200199, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of vitamin E supplementation on clinical manifestations and pulmonary function in children with moderate asthma.", "results_summary": "The study found that vitamin E supplementation significantly increased serum vitamin E levels and improved FEV1 and FEV1/FVC ratios in children with moderate asthma compared to the control group. It concluded that vitamin E could enhance clinical outcomes and pulmonary function in these patients.", "population_specificity": "Children aged 2-17 years with moderate asthma (5-17 years old for the intervention).", "effective_dosage": "50mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:12.688547+00:00"}
{"study_id": 200201, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to understand the differential regulatory effects of vitamin E isoforms (\u03b1-tocopherol and \u03b3-tocopherol) on allergic lung inflammation.", "results_summary": "The study found that \u03b1-tocopherol inhibits allergic inflammation, while \u03b3-tocopherol elevates it at physiological tissue concentrations, highlighting opposing effects of these isoforms.", "population_specificity": "Clinical trials and animal studies (specific human or animal populations not detailed in the abstract).", "effective_dosage": "Physiological tissue concentrations (specific dosage not provided).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:16.758585+00:00"}
{"study_id": 200202, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to systematically review and quantify the effect of antioxidant vitamin E and/or C supplementation on endothelial function in type 2 diabetes mellitus (T2DM) subjects.", "results_summary": "The study found no significant overall improvement in endothelial function with antioxidant vitamin supplementation in T2DM subjects. However, subgroup analysis showed significant improvement in non-obese T2DM subjects (BMI \u2264 29.45 kg/m\u00b2) but not in obese subjects (BMI > 29.45 kg/m\u00b2).", "population_specificity": "Type 2 diabetes mellitus (T2DM) subjects, with subgroup analysis based on BMI (\u2264 29.45 kg/m\u00b2 vs. > 29.45 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:17.300189+00:00"}
{"study_id": 200203, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of neonatal sepsis and vitamin E supplementation on the antioxidative system (AOS) in preterm neonates.", "results_summary": "The study found no difference in AOS activity between controls and septic neonates, but vitamin E supplementation altered some AOS components, such as suppressing glutathione reductase (GR) activity in septic neonates and increasing glutathione peroxidase (GPx) activity in controls. The authors suggest vitamin E supplementation might not be rational for these patients.", "population_specificity": "Preterm neonates (65 total, 34 controls and 31 with sepsis).", "effective_dosage": "25 IU/day for 60 days.", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:17.628609+00:00"}
{"study_id": 200204, "supplement_id": 1664, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to review the properties and applications of Vitamin E TPGS as a drug delivery enhancer, P-glycoprotein inhibitor, and solubilizer for poorly water-soluble drugs.", "results_summary": "The study found that Vitamin E TPGS effectively enhances drug solubility, acts as a P-glycoprotein inhibitor to overcome multidrug resistance, and improves oral bioavailability of anticancer drugs. It also highlighted its use in various formulations like nanocrystals, nanosuspensions, and vaccine adjuvants.", "population_specificity": "Not specified (broad pharmaceutical and therapeutic applications).", "effective_dosage": "Not specified (used at concentrations as low as 0.02 wt%).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:18.430538+00:00"}
{"study_id": 200205, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate changes in serum vitamin E levels before and after isotretinoin therapy in acne patients.", "results_summary": "The study found that serum vitamin E levels decreased significantly during isotretinoin treatment, suggesting a potential link to isotretinoin side effects and indicating that vitamin E supplementation might be beneficial.", "population_specificity": "70 patients with acne treated with isotretinoin in a dermatology department (46 completed the study).", "effective_dosage": "0.6-0.8 mg/kg/d isotretinoin.", "study_duration": "5-7 months.", "interactions": "Interaction with isotretinoin noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:19.406715+00:00"}
{"study_id": 200208, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of Eminol\u00ae, a polyphenol-rich grape extract supplement, on cardiovascular risk and oxidant stress indicators, including Vitamin E levels.", "results_summary": "The study found that Eminol\u00ae supplementation increased Vitamin E levels (11.46 \u00b1 0.5 \u03bcg/ml vs. 9.06 \u00b1 0.5 \u03bcg/ml in placebo, p = 0.018) and improved antioxidant capacity, alongside lowering total and LDL cholesterol.", "population_specificity": "60 volunteers in a randomized, double-blind, placebo-controlled trial.", "effective_dosage": "700 mg of Eminol\u00ae (grape extract) daily.", "study_duration": "56 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:22.008403+00:00"}
{"study_id": 200206, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the best application form (oral vs. intramuscular) to maintain physiological vitamin E levels in growing pigs with exocrine pancreatic insufficiency (EPI), as a model for children with cystic fibrosis.", "results_summary": "Oral supplementation with high doses of vitamin E and an emulsifier maintained liver tocopherol levels comparable to controls, while intramuscular injection showed reduced efficacy. Extra dietary vitamin E was effective in maintaining adequate liver levels in EPI pigs.", "population_specificity": "Growing pigs with induced EPI (as a model for children with cystic fibrosis).", "effective_dosage": "122 mg vitamin E/kg DM (basal diet); PL+ORAL group received additional 600 mg vitamin E/kg DM plus emulsifier; PL+IM group received 3.15 mg/(kg BW \u00b7 wk) aqueous vitamin E and 700 mg (oily)/animal/week.", "study_duration": "8 weeks (from 8 to 16 weeks of age).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:22.457880+00:00"}
{"study_id": 200207, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether oral \u03b1-tocopherol or \u03b3-tocopherol, combined with saline, could effectively prevent contrast-induced acute kidney injury (CI-AKI) in chronic kidney disease (CKD) patients undergoing coronary procedures.", "results_summary": "Both \u03b1-tocopherol and \u03b3-tocopherol significantly reduced CI-AKI incidence compared to placebo (4.9% and 5.9% vs. 14.9%, respectively), with \u03b1-tocopherol showing greater efficacy in high-risk subgroups. The study concluded that these forms of Vitamin E, combined with saline, are effective in protecting against CI-AKI.", "population_specificity": "305 patients with chronic kidney disease (CKD) undergoing elective coronary procedures.", "effective_dosage": "Daily oral medication (specific dosage not mentioned) administered 5 days before and 2 days after the procedure.", "study_duration": "7 days (5 days pre-procedure and 2 days post-procedure).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:23.868220+00:00"}
{"study_id": 200209, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of vitamin E on lifespan in various model organisms through a comprehensive literature review.", "results_summary": "The review found mixed results, with some studies reporting increased lifespan, others showing no effect, and several indicating decreased lifespan due to vitamin E supplementation. The inconsistent outcomes may stem from species-specific differences, varying concentrations, and different forms of vitamin E used.", "population_specificity": "Single-cell organisms, rotifers, Caenorhabditis elegans, Drosophila melanogaster, and laboratory rodents.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:24.912756+00:00"}
{"study_id": 200210, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether adding vitamin E supplementation to pravastatin and homocysteine-lowering therapy improves arterial compliance and distensibility in mild-to-moderate CKD patients.", "results_summary": "The study found that 18 months of combined treatment (pravastatin, vitamin E, and homocysteine-lowering therapy) significantly improved arterial compliance and distensibility in the common carotid and femoral arteries, though it was unclear whether vitamin E alone contributed to these effects. No significant changes were observed in the brachial artery or carotid artery's Young's elastic modulus.", "population_specificity": "Patients with mild-to-moderate chronic kidney disease (CKD).", "effective_dosage": "Not specified", "study_duration": "18 months (vitamin E added after 6 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:26.537851+00:00"}
{"study_id": 200211, "supplement_id": 1664, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine whether vitamin E supplementation could protect erythrocyte membranes from oxidative stress and improve membrane fluidity in healthy middle-aged and elderly people.", "results_summary": "Vitamin E supplementation significantly increased plasma \u03b1-tocopherol levels, reduced oxidative stress markers (malondialdehyde), decreased erythrocyte hemolysis, and improved membrane fluidity, particularly at higher doses (200 mg and 300 mg). Surprisingly, superoxide dismutase activity also decreased.", "population_specificity": "Healthy middle-aged and elderly individuals (55-70 years old).", "effective_dosage": "100 mg, 200 mg, and 300 mg dl-\u03b1-tocopheryl acetate daily.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:27.002755+00:00"}
{"study_id": 200213, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of antioxidant vitamin E supplementation in reducing cardiovascular disease morbidity and mortality specifically in Hp 2-2 diabetic individuals.", "results_summary": "The study suggests that vitamin E supplementation may reduce cardiovascular disease risk in Hp 2-2 diabetic individuals by counteracting the inferior antioxidant protection of the Hp 2-2 protein. Evidence supports Hp genotyping in diabetic individuals to identify those who may benefit from targeted vitamin E therapy.", "population_specificity": "Individuals with diabetes mellitus, particularly those with the Hp 2-2 genotype.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:27.379988+00:00"}
{"study_id": 200214, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether vitamin E supplementation, alone or combined with \u03b1-lipoic acid (ALA), improves markers of insulin resistance, systemic inflammation, and plasma NEFA concentrations in individuals with metabolic syndrome.", "results_summary": "Vitamin E supplementation (alone or with ALA) did not significantly alter fasting glucose, insulin, insulin resistance, adiponectin, or inflammatory markers. ALA alone or combined with vitamin E modestly reduced plasma NEFA concentrations, but vitamin E alone showed no significant effect.", "population_specificity": "Individuals with metabolic syndrome", "effective_dosage": "100 IU/day", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:27.485542+00:00"}
{"study_id": 200216, "supplement_id": 1664, "safety_score": "80", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Vitamin E supplementation could improve performance variables (velocity and oxygen uptake) at fixed blood lactate concentrations in trained runners.", "results_summary": "Vitamin E supplementation did not significantly enhance performance variables (velocity or oxygen uptake) at lactate threshold or onset of blood lactate accumulation compared to placebo. Training alone improved velocity at these thresholds, but Vitamin E had no additional effect.", "population_specificity": "Trained runners (8 male, 4 female)", "effective_dosage": "268 mg\u00b7d\u207b\u00b9", "study_duration": "35 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:30.311606+00:00"}
{"study_id": 200215, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effect of vitamin E on erythrocyte membrane fluidity in beta-thalassemia/Hemoglobin E patients using spin labeling techniques.", "results_summary": "Vitamin E supplementation decreased erythrocyte membrane fluidity, increased plasma vitamin E levels, and reduced serum TBARs, but did not change hemoglobin levels. The placebo group showed increased membrane fluidity.", "population_specificity": "Splenectomized and non-splenectomized beta-thalassemia/Hemoglobin E patients.", "effective_dosage": "350 mg daily", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:30.505708+00:00"}
{"study_id": 200218, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers sought to determine the effects of argan oil supplementation (a source of vitamin E) on plasma lipid profiles and antioxidant status in healthy Algerian subjects.", "results_summary": "Argan oil supplementation increased plasma vitamin E concentrations, reduced total and LDL-cholesterol, lowered triglycerides, and improved antioxidant profiles compared to controls.", "population_specificity": "Healthy Algerian subjects (n=20 intervention, n=20 controls).", "effective_dosage": "15 g/d of argan oil (consumed with toasted bread at breakfast).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:32.964134+00:00"}
{"study_id": 200217, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the tissue concentrations of tocotrienols (TE) and tocopherols (TCP) in vital organs following oral supplementation and assess their potential therapeutic effects.", "results_summary": "Oral TE supplementation significantly increased TE concentrations in blood, skin, adipose, brain, cardiac muscle, and liver. TE supplementation also reduced the MELD score in 50% of liver transplantation patients, compared to 20% in TCP-supplemented patients.", "population_specificity": "Healthy participants and surgical patients (including prospective liver transplantation patients).", "effective_dosage": "200 mg mixed TE (twice daily) or 200 mg \u03b1-TCP (twice daily).", "study_duration": "12 weeks for healthy participants; mean 20 weeks (range 1-96 weeks) for surgical patients.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:34.262737+00:00"}
{"study_id": 200221, "supplement_id": 1664, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether vitamin E supplementation interferes with the potential cardiovascular benefits of exercise.", "results_summary": "The study found no significant changes in lipid levels or markers of oxidative stress and inflammation due to vitamin E supplementation. Vitamin E did not demonstrate favorable effects on oxidative stress and inflammation associated with exercise.", "population_specificity": "455 apparently healthy men and women.", "effective_dosage": "800 IU (soft gel vitamin E or placebo).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:35.202782+00:00"}
{"study_id": 200220, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic properties of vitamin E in preventing cardiovascular events, particularly in end-stage renal disease patients on hemodialysis, and explore its molecular mechanisms beyond antioxidant activity.", "results_summary": "Vitamin E was found to prevent atherosclerosis by interfering with smooth muscle cell proliferation, platelet aggregation, monocyte adhesion, and oxidized LDL uptake, suggesting benefits for primary and secondary cardiovascular prevention. Some epidemiological studies and trials supported its efficacy, though effects may stem from both antioxidant and distinct molecular actions.", "population_specificity": "End-stage renal disease patients on maintenance hemodialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:35.552100+00:00"}
{"study_id": 200222, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether vitamin E supplementation is necessary for exclusively breastfed very low birth weight (VLBW) infants by comparing supplemented and unsupplemented groups.", "results_summary": "The study found no significant difference in vitamin E levels or the vitamin E-to-lipids ratio between supplemented and unsupplemented VLBW infants after 21 days, concluding that routine supplementation is unnecessary.", "population_specificity": "Exclusively breastfed very low birth weight (VLBW) infants (n=44).", "effective_dosage": "Not specified", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:36.039308+00:00"}
{"study_id": 200219, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether Vitamin E supplementation reduces cardiovascular risk through its antioxidant effects, particularly in the context of homocysteine-lowering therapies.", "results_summary": "The study found that while Vitamin E may theoretically reduce atherogenesis via antioxidant effects, recent large clinical trials did not substantiate its efficacy in lowering cardiovascular risk. Confounding factors like concomitant statin and aspirin use may have obscured potential benefits.", "population_specificity": "Humans (specific population not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Concomitant use of statins, acetylsalicylic acid, and folic acid may have influenced results.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:36.467135+00:00"}
{"study_id": 200223, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess whether vitamin E supplementation could improve disease outcomes in patients treated with radiation therapy for localized head and neck cancer.", "results_summary": "The study identified predictors of severe acute and late toxicities from radiation therapy but did not report specific results on vitamin E's efficacy or safety in this context.", "population_specificity": "540 patients treated with radiation therapy for localized head and neck cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:37.731313+00:00"}
{"study_id": 200224, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether vitamin E and C supplementation could influence inflammatory cytokines and their associations after anterior cruciate ligament surgery.", "results_summary": "Vitamins E and C did not effectively reduce IL-1\u03b2 increases but altered the relationships between reciprocally regulated cytokines post-surgery. The placebo group showed greater relative increases in IL-1\u03b2 compared to IL-4 and IL-2 than the antioxidant group.", "population_specificity": "Men undergoing anterior cruciate ligament surgery (n=20, 10 per group).", "effective_dosage": "Not specified", "study_duration": "Approximately 2 weeks before surgery and 3 months after surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:39.668641+00:00"}
{"study_id": 200225, "supplement_id": 1664, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of Vitamin E in immune function, oxidative damage prevention, and its potential benefits in carcinogenesis and ischemic heart disease.", "results_summary": "Vitamin E enhances immune functions, particularly in the elderly and animals, and plays a protective role against oxidative damage, cancer, and atherosclerosis. Deficiency impairs T- and B-cell functions but is rare in well-nourished individuals.", "population_specificity": "Humans, particularly the elderly, and animals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:41.518200+00:00"}
{"study_id": 200227, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 10, "quality_score": 85, "study_goal": "The researchers aimed to systematically evaluate the role of vitamin E supplementation in preventing stroke.", "results_summary": "The study found no statistically significant or clinically important benefit of vitamin E supplementation in preventing stroke, regardless of type, dosage, or population. Pooled results from 13 RCTs showed no significant reduction in stroke risk for any subgroup analyzed.", "population_specificity": "166,282 participants, including healthy individuals and those at high baseline risk.", "effective_dosage": "300 IU/day or more, and less than 300 IU/day.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:43.142392+00:00"}
{"study_id": 200226, "supplement_id": 1664, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of \u03b1-tocopherol (Vitamin E) supplementation, alone or combined with lipoic acid, on lipid profile and insulin sensitivity in type 2 diabetes patients.", "results_summary": "The study found that Vitamin E supplementation improved the vitamin E/total cholesterol ratio significantly but did not significantly affect lipid profile or insulin sensitivity in type 2 diabetes patients.", "population_specificity": "102 type 2 diabetes (DM2) patients", "effective_dosage": "800 mg \u03b1-tocopherol daily", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:44.012706+00:00"}
{"study_id": 200229, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the association between CD36 single nucleotide polymorphisms (SNPs) and plasma \u03b1-tocopherol concentrations in humans.", "results_summary": "The study found that certain CD36 SNPs were associated with lower plasma \u03b1-tocopherol concentrations, with rs1527479 remaining significant after multiple testing corrections. The association was influenced by fasting serum triglycerides and long-chain polyunsaturated fatty acids.", "population_specificity": "Adults from the SU.VI.MAX cohort (n = 621) and adolescents from the HELENA Study (n = 993).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:44.354567+00:00"}
{"study_id": 200228, "supplement_id": 1664, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of three different dosages of tocopherol supplementation on oxidative stress and lipid profiles in Chinese women with metabolic syndrome (MetS).", "results_summary": "Vitamin E supplementation significantly increased plasma VitE concentrations, reduced oxidative stress markers (MDA and erythrocyte hemolysis), and improved lipid profiles (decreased total cholesterol), with the 300 IU/day dose showing the most significant effects. However, it also decreased high-density lipoprotein cholesterol and superoxide dismutase (SOD) activity.", "population_specificity": "Chinese women with metabolic syndrome (MetS).", "effective_dosage": "100 IU/day, 200 IU/day, and 300 IU/day.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:44.912110+00:00"}
{"study_id": 200231, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the role of Vitamin E in kidney disease, particularly its potential benefits when used in modified dialysis membranes.", "results_summary": "The study suggests that Vitamin E may have benefits when incorporated into modified dialysis membranes, but larger amounts beyond the recommended daily allowance are not appropriate or beneficial for renal patients.", "population_specificity": "Patients with kidney disease, particularly those on restricted diets or dialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:45.164431+00:00"}
{"study_id": 200230, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of vitamin E supplementation on glycaemic control in patients with type 2 diabetes.", "results_summary": "Vitamin E supplementation did not improve glycaemic control in unselected type 2 diabetes patients but showed a modest reduction in HbA(\u2081c) in subgroups with inadequate baseline glycaemic control (HbA(\u2081c) \u2265 8%) or low serum vitamin E levels. The pooled mean difference in HbA(\u2081c) changes was -0.58% (P < 0.00001) for these subgroups.", "population_specificity": "Patients with type 2 diabetes, particularly those with inadequate glycaemic control (HbA(\u2081c) \u2265 8%) or low baseline serum vitamin E levels.", "effective_dosage": "Not specified", "study_duration": "At least 8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:46.245104+00:00"}
{"study_id": 200232, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether six months of Vitamin E supplementation, alone or combined with exercise, improves cognitive function in older adults as measured by event-related potentials.", "results_summary": "The study found no significant effect of Vitamin E supplementation on cognitive function (P3 latency or amplitude), though exercise alone improved P3 latency.", "population_specificity": "57 adults aged 60-85 years living in a retirement home in Antalya, Turkey.", "effective_dosage": "900 IU/day orally for 6 months.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:48.024970+00:00"}
{"study_id": 200233, "supplement_id": 1664, "safety_score": "65", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of vitamin E supplementation on the incidence of total, ischaemic, and haemorrhagic stroke through a systematic review and meta-analysis of randomized, placebo-controlled trials.", "results_summary": "Vitamin E had no significant effect on total stroke risk but increased the risk of haemorrhagic stroke by 22% and reduced the risk of ischaemic stroke by 10%. The absolute risk translated to one additional haemorrhagic stroke per 1250 individuals and one fewer ischaemic stroke per 476 individuals taking vitamin E.", "population_specificity": "118,765 participants across nine randomized, placebo-controlled trials.", "effective_dosage": "Not specified in the abstract.", "study_duration": "\u22651 year of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:51.647881+00:00"}
{"study_id": 200235, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoid vaccine challenge in healthy female volunteers.", "results_summary": "TRF supplementation significantly increased plasma vitamin E levels, enhanced interferon-\u03b3 and IL-4 production, reduced IL-6 levels, and augmented anti-TT IgG production compared to placebo.", "population_specificity": "Healthy female volunteers", "effective_dosage": "400 mg of TRF daily", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:52.032691+00:00"}
{"study_id": 200236, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to clarify the limitations of oral tocotrienol administration and explore novel drug-delivery systems to enhance its therapeutic effectiveness in cancer prevention and treatment.", "results_summary": "The study found that oral absorption of tocotrienols is limited due to carrier transporter saturation and down-regulation, but novel prodrug derivatives and nanoparticle delivery systems significantly improved bioavailability and therapeutic response. Combined treatment with traditional chemotherapeutic agents showed synergistic anticancer effects, further enhanced by nanoparticle encapsulation.", "population_specificity": "Animal and human studies (specific population not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Combined treatment with traditional chemotherapeutic agents mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:53.146886+00:00"}
{"study_id": 200238, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Vitamin E supplementation in reducing oxidative stress as a therapy for Alzheimer's disease (AD).", "results_summary": "The study found that Vitamin E supplementation showed promise in moderately severe AD but highlighted limitations of general antioxidant therapies due to the complexity of the redox system. It emphasized the need to consider multiple pathogenic mechanisms when designing antioxidative stress therapy for AD.", "population_specificity": "Patients with moderately severe Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:53.264566+00:00"}
{"study_id": 200234, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of omega-3 supplements versus wheat germ oil on saliva production in patients with Sj\u00f6gren's syndrome.", "results_summary": "The study found no statistically significant difference in salivary secretion (unstimulated or stimulated) or oral inflammation markers between the omega-3 and wheat germ oil groups. Omega-3 supplementation was not significantly better than wheat germ oil for stimulating saliva production.", "population_specificity": "61 patients with Sj\u00f6gren's syndrome.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:54.615948+00:00"}
{"study_id": 200239, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of Vitamin E supplementation in improving biochemical and histological markers in subjects with non-alcoholic steatohepatitis (NASH).", "results_summary": "Vitamin E supplementation improved biochemical and histological markers in subjects with NASH, indicating potential therapeutic benefits for this condition. The study reported some efficacy, though it did not specify the extent of improvement or compare it to other treatments.", "population_specificity": "Subjects with non-alcoholic steatohepatitis (NASH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:54.991830+00:00"}
{"study_id": 200240, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent findings on the molecular genetics of Ataxia with Vitamin E deficiency (AVED), including known mutations and the role of Vitamin E supplementation in symptom improvement.", "results_summary": "Vitamin E supplementation was found to improve symptoms and prevent disease progression in AVED patients, a condition caused by mutations in the TTPA gene. Over 20 mutations have been identified in AVED patients, and the study highlights the clinical resemblance of AVED to Friedreich ataxia.", "population_specificity": "Patients with Ataxia with Vitamin E deficiency (AVED), a rare autosomal recessive neurodegenerative disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:56.793735+00:00"}
{"study_id": 200237, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Vitamin E supplementation, alone or combined with Vitamin D, improves clinical manifestations of atopic dermatitis.", "results_summary": "Vitamin E supplementation (600 IU synthetic all-rac-\u03b1-tocopherol) significantly reduced SCORAD by 35.7%, with a negative association between plasma \u03b1-tocopherol levels and disease severity. Combined with Vitamin D, the reduction was even greater (64.3%).", "population_specificity": "45 atopic dermatitis patients", "effective_dosage": "600 IU synthetic all-rac-\u03b1-tocopherol daily", "study_duration": "60 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:40:57.531133+00:00"}
{"study_id": 200241, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess whether vitamin E supplementation was associated with reduced re-hospitalization in older adults hospitalized with community-acquired pneumonia.", "results_summary": "Vitamin E supplementation was found to be protective against re-hospitalization, with an odds ratio of 0.37 (95% CI: 0.16\u20130.90, P = 0.028). No significant adverse effects or safety concerns were reported.", "population_specificity": "Older adults (aged 65+) hospitalized for community-acquired pneumonia.", "effective_dosage": "Not specified", "study_duration": "Follow-up for re-hospitalization was up to 90 days post-initial hospitalization.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:01.111992+00:00"}
{"study_id": 200244, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether lifelong dietary vitamin E (alpha-tocopherol) supplementation could extend lifespan in mice and explore potential mechanisms, such as anti-cancer effects via the P21 signaling pathway.", "results_summary": "The study found that lifelong vitamin E supplementation increased median lifespan in C57BL/6 mice by 15%, likely due to an anti-cancer effect via induction of the P21 pathway rather than antioxidant properties.", "population_specificity": "C57BL/6 mice", "effective_dosage": "Not specified", "study_duration": "Lifelong", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:01.420247+00:00"}
{"study_id": 200242, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of alpha-tocopherol supplementation compared to gamma-tocopherol, particularly in relation to neurodegenerative disorders like Mild Cognitive Impairment and Alzheimer's Disease.", "results_summary": "The study found that alpha-tocopherol supplementation showed null effects in treating Mild Cognitive Impairment and Alzheimer's Disease, potentially due to its reduction of serum gamma-tocopherol, which may have biological importance. Gamma-tocopherol was noted to be more effective in scavenging harmful free radicals and nitrogen oxygen species linked to inflammation in neurodegenerative disorders.", "population_specificity": "Individuals with Mild Cognitive Impairment and Alzheimer's Disease (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:01.983117+00:00"}
{"study_id": 200243, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 25, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Vitamin E supplementation has a protective role in the primary prevention of colorectal cancer.", "results_summary": "The study found no sufficient evidence that Vitamin E reduces the risk of colorectal cancer incidence (RR: 0.89, CI: 0.76, 1.05; p-value = 0.18). It concluded that Vitamin E does not have a protective effect in preventing colorectal cancer.", "population_specificity": "Adults aged 40 years or above (94,069 participants, randomized to Vitamin E or placebo).", "effective_dosage": "Not specified", "study_duration": "Follow-up period of 7 to 10 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:02.932397+00:00"}
{"study_id": 200245, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the neuroprotective effect of vitamin E supplementation in patients receiving cisplatin chemotherapy to mitigate peripheral neurotoxicity.", "results_summary": "Vitamin E significantly reduced the incidence and severity of neurotoxicity compared to placebo, with a 5.9% incidence in the vitamin E group versus 41.7% in the placebo group and lower neurotoxicity scores (1.4 vs. 4.1). The study concluded that vitamin E has a neuroprotective role against cisplatin-induced peripheral neurotoxicity.", "population_specificity": "Patients treated with cisplatin chemotherapy (108 randomized, 41 analyzed for cumulative dose >300 mg/m\u00b2).", "effective_dosage": "400 mg/day (alpha-tocopherol).", "study_duration": "Started before chemotherapy and continued for 3 months after cisplatin suspension.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:05.439654+00:00"}
{"study_id": 200248, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether vitamin E supplementation reduces muscular and oxidative damage and modulates the inflammatory response induced by eccentric exercise in humans.", "results_summary": "Vitamin E supplementation significantly reduced oxidative stress and muscle damage markers (e.g., lipid peroxidation, protein carbonylation) compared to placebo but did not affect the inflammatory response (TNF-alpha, IL-10 levels).", "population_specificity": "21 healthy participants (mean age 22.5 \u00b1 4 years, weight 68.2 \u00b1 4.9 kg, height 173 \u00b1 4.3 cm).", "effective_dosage": "Not specified in the abstract.", "study_duration": "14 days of supplementation before exercise.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:06.752536+00:00"}
{"study_id": 200250, "supplement_id": 1664, "safety_score": "30", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to review the role of vitamin E in cardiovascular disease, focusing on its antioxidant properties and potential cardioprotective effects.", "results_summary": "Vitamin E showed antioxidant benefits in vitro and animal models but failed to demonstrate significant benefits in clinical trials for cardiovascular disease prevention. It was associated with increased risks of total mortality, heart failure, and hemorrhagic stroke.", "population_specificity": "Middle-aged to older men and women.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:10.510541+00:00"}
{"study_id": 200249, "supplement_id": 1664, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether antioxidant supplementation with Vitamin E could attenuate oxidative stress induced by benznidazole treatment in chronic chagasic cardiac patients.", "results_summary": "Vitamin E supplementation (along with Vitamin C) reduced oxidative stress markers (PC, TBARS, NO) and inflammatory markers, while increasing Vitamin E levels and inhibiting certain enzyme activities, particularly in less severe cardiac stages.", "population_specificity": "41 patients with Chagas' heart disease, classified into different clinical hemodynamic groups (IA, IB, II, III).", "effective_dosage": "800 UI/day of Vitamin E (alongside 500 mg/day of Vitamin C).", "study_duration": "6 months of antioxidant supplementation following 2 months of benznidazole treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:10.641733+00:00"}
{"study_id": 42098, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to examine the relationship between inactive MGP (a marker of vitamin K deficiency) and valvular calcifications, as well as its association with mortality in hemodialysis patients.", "results_summary": "Higher levels of inactive MGP were associated with valvular calcifications and increased mortality risk, though not always statistically significant. Severe valvular calcifications, aortic stenosis, and diabetes were significant mortality risk factors.", "population_specificity": "45 chronic kidney disease (CKD) G5D patients on hemodialysis for 6 months to 10 years.", "effective_dosage": "Not specified", "study_duration": "24 months follow-up", "interactions": "Vitamin K antagonists (warfarin-like drugs) were associated with increased valvular calcifications.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:11.420397+00:00"}
{"study_id": 42100, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to highlight nodular purpura as a rare manifestation of late-onset vitamin K deficiency bleeding (VKDB) in infants and assess treatment response to parenteral Vitamin K.", "results_summary": "The study found that nodular purpura, along with hepatic dysfunction and deranged coagulation profiles, improved with parenteral Vitamin K administration in all four infants, emphasizing its role in treating late-onset VKDB.", "population_specificity": "Infants presenting with nodular purpura and late-onset VKDB.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:14.564787+00:00"}
{"study_id": 200246, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the molecular and cellular activities of alpha-tocopheryl phosphate (alphaTP) and its potential functions as a natural compound, cofactor, and active lipid mediator.", "results_summary": "The study found that alphaTP modulates enzyme activity in vitro, affects cell proliferation, apoptosis, signal transduction, and gene expression in cell culture, and prevents atherosclerosis, ischemia/reperfusion injury, and induces hippocampal long-term potentiation in animal studies. AlphaTP may act as a cofactor, lipid mediator, or alter membrane characteristics.", "population_specificity": "Animal models and cultured cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:15.111970+00:00"}
{"study_id": 42099, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the continuation/discontinuation of vitamin K antagonists (VKAs) and the incidences of bleeding and thromboembolic events in patients with life-limiting diseases.", "results_summary": "Most VKA users continued anticoagulant treatment until near death, with similar rates of bleeding and thromboembolic events during use and after discontinuation. Event rates per 100 person-years were comparable for bleeding (2.6 vs. 2.1), venous thromboembolism (0.2 vs. 0.4), and arterial thromboembolism (3.1 vs. 3.3).", "population_specificity": "18,145 VKA users (median age 81, 49% female) with life-limiting diseases, primarily heart disease (60.0%), hip fracture (18.1%), and cancer (13.5%).", "effective_dosage": "Not specified", "study_duration": "Followed from January 1, 2013, to December 31, 2019 (median survival time 2.03 years).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:15.331902+00:00"}
{"study_id": 200247, "supplement_id": 1664, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential effects of Vitamin E, particularly its isoforms, on the development of atopic diseases in prenatal and early life.", "results_summary": "The study noted conflicting results regarding Vitamin E's effects, suggesting variability in outcomes may be linked to differences in isoforms prevalent in local diets. A meta-analysis indicated antioxidants, including Vitamin E, might protect against atopy, but further controlled trials are needed.", "population_specificity": "Pregnant women and infants (prenatal and early childhood exposure).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:15.782200+00:00"}
{"study_id": 42103, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether vitamin K supplementation could reduce ectopic calcification and improve neurological function in a mouse model of OPLL.", "results_summary": "Vitamin K supplementation improved stride length and inter-limb coordination in mice and significantly reduced ectopic calcification in cervical ligaments. It also increased osteochondrogenic cells expressing Gla-rich protein and circulating concentrations of this calcification inhibitor.", "population_specificity": "ttw mice (a model of cervical OPLL)", "effective_dosage": "Biweekly vitamin K2 injections (exact dosage not specified)", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:18.772829+00:00"}
{"study_id": 42102, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 35, "quality_score": 65, "study_goal": "The researchers aimed to determine the indication for Vitamin K antagonist (VKA) use and factors associated with suboptimal anticoagulation control among patients in northern Tanzania.", "results_summary": "The study found that only 28% of INR tests were within the target range, with poor anticoagulation control linked to lack of health insurance, alcohol consumption, and prolonged intervals between tests. Anticoagulation outcomes improved with frequent INR monitoring and health insurance coverage.", "population_specificity": "Patients on long-term VKA therapy in northern Tanzania.", "effective_dosage": "Not specified", "study_duration": "Data collected from 1st January 2020 to 31st December 2022 (retrospective analysis).", "interactions": "Alcohol consumption was associated with poor anticoagulation control.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:20.025905+00:00"}
{"study_id": 42104, "supplement_id": 1665, "safety_score": "85", "efficacy_score": 90, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of prophylactic vitamin K2 injections in preventing severe coagulopathy in a case of warfarin overdose.", "results_summary": "Prophylactic vitamin K2 injections administered before INR elevation successfully prevented severe coagulopathy or bleeding in a warfarin overdose case, despite high initial warfarin concentration. The patient recovered without complications after stopping vitamin K2.", "population_specificity": "A 41-year-old woman with warfarin overdose and suicidal intent.", "effective_dosage": "Continuous menaquinone-4 (vitamin K2) injections (specific dosage not provided).", "study_duration": "72 hours.", "interactions": "Warfarin (vitamin K antagonist).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:21.002829+00:00"}
{"study_id": 42105, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antimicrobial effect of Vitamin K3 (VK3)-mediated photodynamic inactivation (PDI) against Pseudomonas fluorescens and its impact on the quality of blunt bream.", "results_summary": "VK3-mediated PDI significantly inactivated P. fluorescens (>7.0 log10 cfu/ml) and disrupted cellular integrity, leading to bacterial death. It also slowed bacterial proliferation in blunt bream fillets and maintained fish quality during storage.", "population_specificity": "Pseudomonas fluorescens and blunt bream fillets (aquatic food product).", "effective_dosage": "1 mM and 1.5 mM VK3 with UV-A irradiation for 45-60 minutes.", "study_duration": "Single treatment session (45-60 minutes).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:24.423728+00:00"}
{"study_id": 42107, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of new oral anticoagulants (NOACs) versus warfarin for treating deep venous thrombosis (DVT).", "results_summary": "NOACs showed superior efficacy in achieving vascular patency and better safety profiles with lower incidences of major bleeding, adverse events, and post-thrombotic syndrome compared to warfarin. Subgroup analysis indicated improved preventive efficacy against PTS with longer follow-up periods.", "population_specificity": "10,084 patients with deep venous thrombosis (6,704 receiving NOACs, 3,380 receiving warfarin).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:24.804736+00:00"}
{"study_id": 42106, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 40, "study_goal": "The researchers were examining the potential benefits of non-vitamin K antagonist oral anticoagulants (NOACs) in managing coronary artery ectasia (CAE) in acute coronary syndrome, not Vitamin K itself.", "results_summary": "The study found that triple therapy (dual antiplatelet therapy and NOACs) led to complete resolution of occlusion and thrombus dissolution in two CAE cases. No direct findings on Vitamin K were reported.", "population_specificity": "Two male patients with coronary artery ectasia presenting as acute coronary syndrome (ages 36 and 53).", "effective_dosage": "Not mentioned for Vitamin K.", "study_duration": "1 year for the first patient, 2 months for the second.", "interactions": "None mentioned for Vitamin K.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:24.955321+00:00"}
{"study_id": 42108, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of early versus later initiation of non-vitamin K antagonist oral anticoagulants (NOACs) in atrial fibrillation patients with acute ischemic stroke.", "results_summary": "Early NOAC therapy showed nonsignificant reductions in primary outcomes, recurrent ischemic stroke, death, and systemic embolism compared to later therapy, with no increased bleeding risk. Subgroup analysis suggested greater benefit for female patients.", "population_specificity": "Atrial fibrillation patients with acute ischemic stroke (n=6442).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:25.778712+00:00"}
{"study_id": 42109, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of Vitamin K1 (phytomenadione) in correcting the effects of indirect anticoagulants in patients with hemorrhagic stroke.", "results_summary": "The study found that Vitamin K1, administered parenterally, is necessary alongside prothrombin complex or factor VIIa to correct the effects of indirect anticoagulants, though the safety and efficacy of these methods in hemorrhagic stroke patients remain unproven.", "population_specificity": "Patients with hemorrhagic stroke, particularly those on anticoagulants or antiplatelet agents.", "effective_dosage": "Not specified (only mentions parenteral administration).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:27.282864+00:00"}
{"study_id": 42110, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to investigate the unrecognized drug-drug interaction between mesalamine and vitamin K antagonists, leading to severe vitamin K depletion and life-threatening bleeding.", "results_summary": "The study found that mesalamine may interact with vitamin K antagonists (warfarin), causing severe depletion of vitamin K-dependent coagulation factors, resulting in supratherapeutic anticoagulation and gastrointestinal bleeding.", "population_specificity": "A 76-year-old male patient with a history of aortic valve replacement and ulcerative colitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Mesalamine and vitamin K antagonists (warfarin)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:28.750543+00:00"}
{"study_id": 42111, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the safety and efficacy of vitamin K antagonists (VKAs) versus direct oral anticoagulants (DOACs) in treating venous thromboembolism (VTE) in patients with antiphospholipid syndrome (APS).", "results_summary": "The study found no significant differences in thrombotic recurrence (16.1% for VKAs vs. 15.8% for DOACs) or major bleeding (6.45% for VKAs vs. 0% for DOACs) between the two treatments. DOACs showed comparable outcomes to VKAs in APS patients with VTE.", "population_specificity": "APS patients with VTE (n=50, 31 on VKAs, 19 on DOACs).", "effective_dosage": "Not specified", "study_duration": "One-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:31.477299+00:00"}
{"study_id": 42113, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the association between functional vitamin K status (measured via plasma dp-ucMGP) and cardiovascular disease risk factors.", "results_summary": "Higher dp-ucMGP levels (indicating poorer vitamin K status) were associated with increased risks of central obesity, diabetes, hyperlipidaemia, and impaired kidney function, but not with hypertension or arterial stiffness.", "population_specificity": "4,092 individuals aged 24-77 years from a Danish population-based health examination study.", "effective_dosage": "Not specified", "study_duration": "Not specified (cross-sectional study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:33.230850+00:00"}
{"study_id": 42114, "supplement_id": 1665, "safety_score": "70", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the safety and efficacy of phytonadione (Vitamin K) for warfarin reversal in a patient with an elevated INR.", "results_summary": "IV phytonadione caused a severe infusion-related reaction, but oral phytonadione (1.25 mg and 5 mg) was well tolerated and successfully lowered the INR to the target level within 24 hours.", "population_specificity": "A woman in her early 60s on warfarin for atrial fibrillation with a contained small bowel perforation and elevated INR.", "effective_dosage": "1.25 mg and 5 mg orally, administered once each.", "study_duration": "Less than 24 hours.", "interactions": "Warfarin (INR reduction).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:34.649549+00:00"}
{"study_id": 42112, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of DOACs and VKAs (including Vitamin K antagonists) on thromboelastometry and thrombin generation in chronically anticoagulated patients.", "results_summary": "The study found that thromboelastometry clotting time (CT) was responsive to hypocoagulability induced by both DOACs and VKAs, but clot formation time and maximal clot formation were not. VKAs showed greater responsiveness in parameters denoting thrombin generation quantity (peak-thrombin, ETP) compared to DOACs, while DOACs showed more responsiveness in thrombin generation velocity parameters (lag time, time-to-peak). Apixaban demonstrated stable anticoagulation with small peak vs. trough differences.", "population_specificity": "131 patients on DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) and 33 on VKAs.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) were compared, but no other interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:36.098438+00:00"}
{"study_id": 42116, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the safety and efficacy of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) in managing left ventricular thrombus, particularly in patients with or without recent acute coronary syndrome.", "results_summary": "DOACs showed lower rates of stroke, major bleeding, and systemic embolism compared to VKAs in both the overall cohort and subgroups, with no significant differences in all-cause mortality. The results suggest DOACs are more effective and safer than VKAs for this condition.", "population_specificity": "Patients with left ventricular thrombus, including subgroups with or without recent acute coronary syndrome (<1 month).", "effective_dosage": "Not specified", "study_duration": "Outcomes assessed at 90 days after the indexed event.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:36.693875+00:00"}
{"study_id": 42117, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to analyze the consequences of poor anticoagulation control with vitamin K antagonists (VKAs) in Spanish patients with non-valvular atrial fibrillation (NVAF), focusing on cardiovascular events, bleeding, mortality, healthcare resource use, and costs.", "results_summary": "Patients with poor anticoagulation control had a 75% higher probability of cardiovascular events compared to those with adequate control. Adequate control reduced cardiovascular events, major and minor bleeding, systemic thromboembolism, and ischemic strokes by significant percentages (16.1% to 46.2%) and saved EUR 455 per patient due to reduced hospitalizations.", "population_specificity": "Spanish patients with non-valvular atrial fibrillation (NVAF) who started VKA treatment between 2016 and 2018.", "effective_dosage": "Not specified", "study_duration": "Two years of follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:38.610248+00:00"}
{"study_id": 42101, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of Vitamin K-dependent PRRG1 in pancreatic ductal adenocarcinoma (PDAC) progression and the potential therapeutic effect of warfarin, a Vitamin K antagonist.", "results_summary": "PRRG1, a Vitamin K-dependent protein, was found to promote PDAC malignancy by interacting with NEDD4, destabilizing KRAS and EGFR, and enhancing tumor growth. Warfarin inhibited PRRG1's pro-tumorigenic effects, suggesting its potential as a therapeutic strategy.", "population_specificity": "Pancreatic ductal adenocarcinoma (PDAC) patients and cell lines.", "effective_dosage": "Low-dose warfarin (specific dosage not mentioned).", "study_duration": "Not specified.", "interactions": "Warfarin (Vitamin K antagonist) was noted to inhibit PRRG1's effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:40.884263+00:00"}
{"study_id": 42118, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy and safety of prompt systematic reversal of anticoagulation with 4f-PCC in patients on vitamin K antagonists (VKAs) presenting with recent mild traumatic brain injury (TBI).", "results_summary": "Systematic immediate reversal with 4f-PCC did not statistically significantly reduce intracranial hemorrhage (ICH) rates at 24 hours compared to standard care (6.1% vs. 12.1%, P=0.215), though the study was prematurely stopped, leaving potential clinical benefits unconfirmed.", "population_specificity": "Patients on VKAs who experienced mild TBI within the last 6 hours and had a Glasgow Coma Score \u226513.", "effective_dosage": "25 IU/kg of 4f-PCC.", "study_duration": "Single administration before initial cranial CT scan.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:41.272910+00:00"}
{"study_id": 42119, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to characterize Vitamin K-dependent coagulation factors deficiency (VKCFD), its diagnostic challenges, genetic mutations (GGCX and VKORC1), and therapeutic options involving Vitamin K supplementation.", "results_summary": "The study found that VKCFD is a rare genetic disorder with heterogeneous manifestations, often mimicking acquired Vitamin K deficiencies. Vitamin K supplementation, coagulation factors, and fresh frozen plasma are therapeutic options, though effectiveness may vary based on genetic mutations.", "population_specificity": "Patients with VKCFD (50 affected families reported) and two case studies (one with inherited GGCX mutation, one with acquired deficiency due to Crohn's disease).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:42.768056+00:00"}
{"study_id": 42120, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the pro-oxidant vitamin K precursor menadione sodium bisulfite (MSB) could suppress prostate cancer progression and improve muscle function in a myotubular myopathy model.", "results_summary": "MSB suppressed prostate cancer progression in mice by inducing oxidative cell death and improved muscle histology, function, and lifespan in a myotubular myopathy model. The study identified MSB's mechanism of action as antagonizing VPS34 through cysteine oxidation.", "population_specificity": "Mice with prostate cancer and a myotubular myopathy model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:43.161590+00:00"}
{"study_id": 42121, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of the COVID-19 pandemic on vitamin K antagonist (VKA) treatment control in patients with mechanical prosthetic heart valves.", "results_summary": "The study found that VKA control worsened during the COVID-19 pandemic, with significantly lower time in therapeutic range (TTR) and fewer INR tests compared to the preceding year. Poor VKA control was observed overall, with a high percentage of patients lacking documented INR tests.", "population_specificity": "Patients with mechanical prosthetic heart valves (aortic or mitral valve replacement).", "effective_dosage": "Not specified", "study_duration": "1 year (first year of COVID-19 pandemic compared to the preceding year).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:45.069831+00:00"}
{"study_id": 42123, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the safety and effectiveness of apixaban and vitamin K antagonists (VKAs) in managing atrial fibrillation (AF) in patients with end-stage kidney disease (ESKD) undergoing dialysis.", "results_summary": "The review found mixed results, with some studies showing apixaban had a reduced risk of thromboembolic events and major bleeding compared to VKAs, while others found no significant differences in safety or effectiveness outcomes between the two treatments.", "population_specificity": "Patients with atrial fibrillation and end-stage kidney disease undergoing dialysis.", "effective_dosage": "Not specified", "study_duration": "Varies by study (e.g., 2-year follow-up in one retrospective review)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:45.196536+00:00"}
{"study_id": 42115, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were assessing the utility of \"days alive and out of hospital\" (DAOH) as a clinical trial endpoint for antithrombotic therapies (apixaban vs. warfarin and aspirin vs. placebo) in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention.", "results_summary": "The study found no significant differences in DAOH between treatment groups (apixaban vs. warfarin or aspirin vs. placebo). However, apixaban increased the proportion of patients who neither died nor were hospitalized compared to warfarin.", "population_specificity": "Patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention (n=4614).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:45.782225+00:00"}
{"study_id": 42124, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 95, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether intravenous vitamin K prophylaxis could prevent cefoperazone-sulbactam-induced coagulopathy in critically ill patients.", "results_summary": "The study found that weekly 10 mg intravenous vitamin K significantly reduced the hazard of coagulopathy by 99% and improved survival probability from bleeding compared to the control group. The intervention group showed markedly better outcomes in preventing coagulopathy and bleeding.", "population_specificity": "Critically ill adult patients treated with cefoperazone-sulbactam.", "effective_dosage": "10 mg intravenous vitamin K weekly.", "study_duration": "Until cefoperazone-sulbactam therapy ended.", "interactions": "Cefoperazone-sulbactam (antibiotic).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:48.228437+00:00"}
{"study_id": 42125, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the quality of life (QoL) and patient satisfaction between atrial fibrillation patients treated with Vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs).", "results_summary": "Patients on VKAs reported worse QoL (more mobility limitations, activity restrictions, pain/discomfort) and lower satisfaction (higher burden, negative impact) compared to those on DOACs, though VKA treatment was not an independent factor for worse EQ-5D results after adjustment.", "population_specificity": "Atrial fibrillation patients treated by cardiologists (904 total: 532 on VKAs, 372 on DOACs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:50.319514+00:00"}
{"study_id": 42126, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the levels of vitamin-K-dependent proteins (MGP and GRP) in the synovial fluid of osteoarthritic and non-osteoarthritic knee joints to assess their potential as biomarkers for osteoarthritis.", "results_summary": "The study found significantly higher levels of GRP and MGP in the synovial fluid of osteoarthritic knees compared to non-osteoarthritic knees, suggesting these proteins may serve as biomarkers for osteoarthritis. GRP was noted as more valuable due to its lack of association with age.", "population_specificity": "Patients with grade 4 primary degenerative osteoarthritis (OA group) and individuals undergoing arthroscopic surgery for non-cartilage-related issues (non-OA group).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:50.852886+00:00"}
{"study_id": 42127, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine the dual roles of non-vitamin K oral anticoagulants (NOACs) as anticoagulants and modulators of inflammation via protease-activated receptor (PAR) signaling.", "results_summary": "The study found that NOACs (apixaban, rivaroxaban, edoxaban, and dabigatran) are effective in preventing thromboembolic events and also influence inflammation through PAR signaling pathways, potentially impacting conditions like atherosclerosis and diabetes.", "population_specificity": "Not specified (general review of clinical trials and emerging research).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:51.661111+00:00"}
{"study_id": 42128, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) and type 2 valvular heart disease (VHD).", "results_summary": "NOACs reduced the risk of stroke/systemic embolism and intracranial hemorrhage compared to VKAs, with no significant difference in major bleeding. For patients with bioprosthetic heart valves, NOACs showed superior efficacy in reducing stroke/systemic embolism risks.", "population_specificity": "Patients with atrial fibrillation and type 2 valvular heart disease (excluding moderate to severe rheumatic mitral stenosis or mechanical heart valves).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:51.996052+00:00"}
{"study_id": 42130, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in low-weight patients with atrial fibrillation.", "results_summary": "NOACs were associated with a lower risk of any bleeding event in low-weight patients compared to warfarin, but no significant differences were found in risks of ischemic stroke/systemic embolism, major bleeding, or other ischemic events.", "population_specificity": "Low-weight (\u226460 kg) and non-low-weight (60-100 kg) patients with atrial fibrillation.", "effective_dosage": "Not specified", "study_duration": "Data extracted from July 2011 to September 2022 (retrospective analysis)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:54.078930+00:00"}
{"study_id": 42129, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate abnormalities in FII/FIIE ratios among patients with coagulopathies and determine if these findings could predict improvement after Vitamin K treatment.", "results_summary": "The study found that FII/FIIE ratios and FIIE-FII differences had modest sensitivity and specificity for diagnosing Vitamin K deficiency (VKD), with ratios \u22640.84-0.91 and differences >0.04 U/mL being predictive. Patients with probable VKD showed similar mortality and bleeding rates but required less plasma and fibrinogen replacement.", "population_specificity": "292 patients (58.2% male, 85.6% adults, median age 73 years), mostly hospitalized (84.2%), with 48.3% in intensive care and 71.6% having active liver disease.", "effective_dosage": "Not specified", "study_duration": "Retrospective analysis spanning 2002-2021", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:55.281010+00:00"}
{"study_id": 42131, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of factor Xa inhibitors (rivaroxaban, apixaban, edoxaban) versus vitamin K antagonists (VKAs) in preventing stroke or systemic embolism and major bleeding in AF patients on dialysis.", "results_summary": "Factor Xa inhibitors were associated with a reduced risk of stroke or systemic embolism compared to VKAs, with no significant difference in major bleeding. Observational studies supported these findings.", "population_specificity": "Patients with atrial fibrillation (AF) and end-stage kidney disease (ESKD) undergoing dialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:55.540205+00:00"}
{"study_id": 42132, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the correlation between clinical anticoagulation parameters and plasma levels of different vitamin K forms (VK1, MK-4, MK-7) in cardiovascular patients.", "results_summary": "The study found that MK-7 and total vitamin K concentrations were significantly correlated with initial anticoagulation (INR0). Baseline concentrations of VK1, MK-4, and MK-7 were quantified, suggesting potential relevance in adjusting anticoagulation dosage.", "population_specificity": "Cardiovascular patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:56.195236+00:00"}
{"study_id": 42133, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to investigate the role of Vitamin K in correcting coagulopathy caused by antimicrobial agents in a malnourished patient with a postoperative lumbar spine infection.", "results_summary": "The study found that Vitamin K administration rapidly normalized coagulation parameters in a patient with severe deficiency, confirming its efficacy in treating coagulopathy induced by antimicrobial therapy and malnutrition. The patient's coagulation status improved within hours of Vitamin K administration and remained stable with continued treatment.", "population_specificity": "A 70-year-old malnourished male with diabetes mellitus and a postoperative lumbar spine infection.", "effective_dosage": "40 mg as a test dose, followed by continued administration for four days.", "study_duration": "Four days of Vitamin K administration.", "interactions": "Cefazolin and rifampicin were noted to suppress Vitamin K-producing bacteria, contributing to deficiency.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:41:59.995745+00:00"}
{"study_id": 42136, "supplement_id": 1665, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) in treating left ventricular thrombus (LVT).", "results_summary": "DOACs showed similar rates of thromboembolic and hemorrhagic events, as well as thrombus resolution, compared to VKAs. Rivaroxaban, a specific DOAC, significantly reduced thromboembolic events compared to VKAs.", "population_specificity": "Patients with left ventricular thrombus (LVT).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:00.369863+00:00"}
{"study_id": 42134, "supplement_id": 1665, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and safety of vitamin-K antagonist (VKA) therapy versus dual antiplatelet therapy (DAPT) in managing patients with isolated and non-obstructive atherosclerotic coronary artery ectasia (CAE).", "results_summary": "Cumulative adverse events were comparable between VKA and DAPT groups over nine months, but VKA showed significantly higher event-free survival beyond the first three months. Recurrent events were more frequent in the DAPT group, and no major bleeding events occurred in either group.", "population_specificity": "79 patients diagnosed with isolated or non-obstructive atherosclerotic CAE via elective coronary angiography.", "effective_dosage": "Not specified (warfarin used as VKA, aspirin plus clopidogrel as DAPT).", "study_duration": "Nine months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:00.779488+00:00"}
{"study_id": 42139, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to synthesize existing information on Vitamin K's properties, mechanisms, and potential uses for disease treatment or prevention.", "results_summary": "The study highlights Vitamin K's broad health benefits, including support for brain, cardiovascular, bone, and immune functions, and its synergistic effects with Vitamin D for circulatory and skeletal health.", "population_specificity": "Not specified (general human and domesticated animal health).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:02.546350+00:00"}
{"study_id": 42135, "supplement_id": 1665, "safety_score": "85", "efficacy_score": 95, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the hemostatic noninferiority of an investigational 4-factor prothrombin complex concentrate (4F-PCC) compared to a control 4F-PCC for rapid vitamin K antagonist (VKA) reversal before urgent surgery.", "results_summary": "The investigational 4F-PCC was noninferior to the control 4F-PCC, achieving effective hemostasis in 94.3% vs. 94.2% of patients, with similar safety profiles. Thrombotic events and mortality rates were within expected ranges for 4F-PCC use.", "population_specificity": "Adult patients taking VKAs with an INR \u22652 who required urgent surgery with substantial bleeding risk (\u226550 mL).", "effective_dosage": "25, 35, or 50 IU/kg based on baseline INR (2 to <4, 4-6, or >6, respectively).", "study_duration": "Single intravenous infusion (median infusion time: 12-13 minutes).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:02.706688+00:00"}
{"study_id": 42140, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of long-term oral anticoagulation therapies (VKAs and DOACs) against LMWH in cancer patients with pulmonary embolism.", "results_summary": "The study found that LMWH is the gold standard for anticoagulation therapy in cancer patients, with VKAs and DOACs being viable alternatives, though their comparative efficacy is explored.", "population_specificity": "Cancer patients with pulmonary embolism.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:03.953195+00:00"}
{"study_id": 42138, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in patients with chronic thromboembolic pulmonary hypertension (CTEPH).", "results_summary": "NOACs showed significantly lower all-cause mortality and major bleeding compared to VKAs, with no significant differences in VTE recurrence, total bleeding, or minor bleeding. The study concluded that NOACs might be a safer and more convenient alternative to VKAs for CTEPH treatment.", "population_specificity": "Patients with chronic thromboembolic pulmonary hypertension (CTEPH) (n=4556).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:04.345502+00:00"}
{"study_id": 42137, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether vitamin K inhibition by the vitamin K antagonist Marcumar affects coronary and valvular calcification progression in patients requiring prolonged oral anticoagulation.", "results_summary": "The study found no significant difference in coronary calcification progression between patients taking Rivaroxaban and Marcumar after 12 and 24 months. However, dephosphorylated, uncarboxylated matrix Gla Protein (Dp-ucMGP) significantly decreased in the VKA group, suggesting a biochemical effect without clinical impact on calcification.", "population_specificity": "Patients with baseline coronary or valvular calcification and an indication for prolonged oral anticoagulation therapy.", "effective_dosage": "Not specified", "study_duration": "Up to 24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:04.886919+00:00"}
{"study_id": 42142, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) in patients with atrial fibrillation and liver cirrhosis.", "results_summary": "DOACs were associated with a significantly lower risk of stroke or systemic embolism and major bleeding compared to VKAs, with comparable all-cause mortality between the two groups.", "population_specificity": "Patients with atrial fibrillation and concurrent liver cirrhosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:08.006920+00:00"}
{"study_id": 42143, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to assess the impact of reduced Vitamin K intake due to emergency rations on PT-INR levels in LVAD patients during a disaster.", "results_summary": "Reduced Vitamin K content in emergency rations led to significantly higher PT-INR levels on day 2 compared to day 1, suggesting a need for close monitoring of Vitamin K intake in LVAD patients during disasters.", "population_specificity": "Patients with left ventricular assist devices (LVAD) affected by the 2018 Osaka earthquake.", "effective_dosage": "Not specified", "study_duration": "2 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:08.723329+00:00"}
{"study_id": 42141, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the outcomes (stroke and bleeding) of warfarin (a vitamin K antagonist) versus nonvitamin K oral antagonist (NOAC) therapy in patients with left ventricular thrombus (LVT).", "results_summary": "The study found that NOAC was as effective as VKA in stroke prevention without increasing the risk of major bleeding, though minor bleeding was significantly lower in the VKA group. Unmatched analysis showed higher all bleeding events with NOAC, but matched analysis revealed no significant differences in overall bleeding, major bleeding, or stroke between the groups.", "population_specificity": "Patients with echocardiography-confirmed left ventricular thrombus (LVT) (n = 201).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 17 months (25th-75th percentiles: 8-38).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:11.155273+00:00"}
{"study_id": 42145, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in the first three months after surgical mitral valve repair or bioprosthetic valve replacement.", "results_summary": "NOACs were associated with fewer adverse events (6% vs. 22.4%) compared to VKAs, primarily due to reduced bleeding. VKAs were independently linked to a threefold higher risk of adverse outcomes.", "population_specificity": "Patients who underwent surgical mitral valve repair or bioprosthetic valve replacement (mean age 65.5\u00b112.2 years, 56.8% male).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:11.983068+00:00"}
{"study_id": 42144, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether prior use of vitamin K antagonists (VKAs) increased the risk of symptomatic intracranial hemorrhage (sICH) in patients undergoing endovascular thrombectomy (EVT).", "results_summary": "The study found that prior VKA use did not increase sICH risk overall, but recent VKA use with an INR > 1.7 was associated with a significantly higher risk of sICH. Future large-scale trials are needed to clarify EVT effects in anticoagulated stroke patients.", "population_specificity": "Patients under vitamin K antagonist (VKA) use within 7 days prior to hospital admission for ischemic stroke.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "VKA use with INR > 1.7 was associated with increased sICH risk.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:12.469739+00:00"}
{"study_id": 42146, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare adverse kidney outcomes and net clinical benefit in patients with atrial fibrillation and advanced chronic kidney disease receiving rivaroxaban versus vitamin K antagonists (VKAs).", "results_summary": "Rivaroxaban was associated with fewer adverse kidney outcomes and lower all-cause mortality compared to VKAs, but no significant differences were observed in net clinical benefit.", "population_specificity": "Patients with atrial fibrillation and an estimated glomerular filtration rate (eGFR) of 15 to 49 mL/min/1.73 m\u00b2.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 2.1 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:12.739410+00:00"}
{"study_id": 42148, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of Newer Oral Anticoagulants (NOACs) versus Vitamin K Antagonists (VKAs) in managing Cerebral Venous Thrombosis (CVT).", "results_summary": "NOAC-treated patients showed significantly higher complete recanalization rates (58.5% vs. 31.1%) and better functional outcomes at weeks 8 and 12 compared to VKA-treated patients, with similar bleeding risks and milder adverse events.", "population_specificity": "Adult CVT patients in a single-center Indian cohort.", "effective_dosage": "Not specified", "study_duration": "Follow-up at weeks 8 and 12", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:13.643130+00:00"}
{"study_id": 42149, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to compare the impact of vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs) on major organ hemorrhage events in patients with acute venous thromboembolism (VTE).", "results_summary": "The study found nuanced differences in bleeding patterns, with DOACs showing a higher incidence of intracranial bleeding (55.5%) and VKAs showing more upper gastrointestinal bleeding (50%). Mortality rates were lower with DOACs (18.2%) compared to VKAs (33.3%), though differences were not statistically significant.", "population_specificity": "46 patients diagnosed with VTE and treated with either VKAs or DOACs.", "effective_dosage": "Not specified", "study_duration": "Outcomes assessed within 30 days of hospital admission.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:14.182631+00:00"}
{"study_id": 42150, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess thrombotic and hemorrhagic risks in atrial fibrillation patients taking non-vitamin K antagonist oral anticoagulants (NOACs) with antiseizure medications (ASMs) compared to those on NOACs or ASMs alone.", "results_summary": "The study found that patients on combined NOAC and ASM therapy had a higher risk of ischemic stroke, transient ischemic attack, and major bleeding compared to those on NOACs alone, with no events in the ASM-only group. This suggests an increased risk for patients on combined therapy, highlighting the need for careful drug interaction consideration.", "population_specificity": "Atrial fibrillation and epilepsy patients on NOACs and/or ASMs.", "effective_dosage": "Not specified", "study_duration": "3-year follow-up", "interactions": "Increased risk of adverse outcomes when NOACs are combined with ASMs.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:17.740508+00:00"}
{"study_id": 42151, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the cost-effectiveness of non-vitamin K antagonist oral anticoagulants (NOACs) compared to warfarin in treating atrial fibrillation (AF) patients in Thailand.", "results_summary": "NOACs were found to be a cost-saving alternative to warfarin, with marginally lower lifetime costs and slight gains in life years and quality-adjusted life years (QALYs). However, the probability of NOACs being cost-effective was below 65%, indicating some uncertainty in their overall cost-effectiveness compared to warfarin.", "population_specificity": "AF patients in Thailand (mean age 68.8 \u00b1 10.7 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:18.209911+00:00"}
{"study_id": 42152, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the serum metabolomic and lipoproteomic profiles of atrial fibrillation patients treated with vitamin K antagonists (VKAs) versus direct oral anticoagulants (DOACs).", "results_summary": "The study found that patients on DOACs had lower levels of alanine, lactate, and certain lipoprotein fractions, but higher levels of HDL cholesterol and apolipoprotein A1 compared to those on VKAs, suggesting distinct metabolic effects. These differences may contribute to the reduced cardiovascular risk observed with DOACs.", "population_specificity": "167 atrial fibrillation patients (median age 78 years, 62% male, 70% on DOACs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:20.405146+00:00"}
{"study_id": 42154, "supplement_id": 1665, "safety_score": "75", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to compare the safety and outcomes of direct oral anticoagulants (DOACs) versus vitamin-K antagonists (VKAs) in patients with chronic thromboembolic pulmonary hypertension (CTEPH).", "results_summary": "The study found no statistically significant differences between DOACs and VKAs in terms of all-cause mortality, venous thromboembolism, major bleeding, or clinically relevant nonmajor bleeding, suggesting DOACs are noninferior to VKAs in CTEPH management.", "population_specificity": "Patients with chronic thromboembolic pulmonary hypertension (CTEPH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:21.134632+00:00"}
{"study_id": 42156, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were attempting to determine the efficacy and safety of direct oral anticoagulants (DOACs) in Japanese patients with venous thromboembolism (VTE).", "results_summary": "The study found incidences of recurrent symptomatic VTE (3.2%) and major bleeding (2.2%) over 52 weeks. Chemotherapy and anemia were identified as significant risk factors for recurrent VTE and major bleeding, respectively.", "population_specificity": "Japanese patients with acute symptomatic pulmonary thromboembolism and proximal deep vein thrombosis (DVT) or isolated calf DVT (mean age 66.3\u00b115.1 years; 58.6% females).", "effective_dosage": "Not specified", "study_duration": "52 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:21.941904+00:00"}
{"study_id": 42157, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze the scientific literature on gene polymorphisms involved in the metabolism of direct oral anticoagulants (DOACs) to optimize pharmacotherapy and reduce hemorrhagic complications.", "results_summary": "The review found that polymorphisms affecting DOACs vary, which could help develop individualized approaches for safer and more effective treatment, but large-scale studies are needed to confirm dosage recommendations based on genotyping.", "population_specificity": "Patients aged 18-75 years with non-valvular atrial fibrillation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:22.143839+00:00"}
{"study_id": 42153, "supplement_id": 1665, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of oral vitamin K for managing supratherapeutic INR levels (\u22655.0) in non-bleeding outpatients on warfarin.", "results_summary": "Vitamin K was administered in 7% of episodes (INR \u22656), achieving INR correction in 57% of cases with minimal bleeding complications (1.2%) and no thrombotic events. Overcorrection occurred in 15% of episodes.", "population_specificity": "Non-bleeding outpatients on warfarin with INR \u22655.0, excluding high thrombotic risk patients.", "effective_dosage": "Not specified", "study_duration": "30-day follow-up", "interactions": "Warfarin (anticoagulant)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:22.425019+00:00"}
{"study_id": 42158, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of a standardized protocol for perioperative management of direct factor Xa inhibitors (not Vitamin K) in atrial fibrillation patients undergoing minor bleeding risk procedures.", "results_summary": "The study does not report results for Vitamin K, as it focuses on perioperative management of direct factor Xa inhibitors (apixaban, edoxaban, rivaroxaban) in atrial fibrillation patients.", "population_specificity": "Patients with atrial fibrillation undergoing minor bleeding risk procedures (e.g., gastrointestinal endoscopy, selected dental procedures, ocular surgery).", "effective_dosage": "Not mentioned for Vitamin K.", "study_duration": "Not mentioned for Vitamin K.", "interactions": "None mentioned for Vitamin K.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:22.943906+00:00"}
{"study_id": 42159, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to compare the safety and efficacy of apixaban versus vitamin K antagonists (VKAs) in patients undergoing dialysis.", "results_summary": "Apixaban was associated with significantly lower risks of major bleeding, clinically relevant non-major bleeding, gastrointestinal bleeding, and intracranial bleeding compared to VKAs, but no differences were found in ischemic stroke, mortality, or recurrent venous thromboembolism. Subgroup analysis of RCTs showed no difference in bleeding outcomes.", "population_specificity": "Patients on dialysis", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:27.122145+00:00"}
{"study_id": 42160, "supplement_id": 1665, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical outcomes (symptom recurrence, thrombus resolution, and bleeding complications) of vitamin K antagonists versus non-vitamin K antagonist oral anticoagulants in patients with mesenteric vein thrombosis.", "results_summary": "The study found no recurrence of symptoms in either group, with thrombus resolution (complete or partial) observed in 90% of cases. Bleeding complications occurred in two patients in the non-vitamin K antagonist group, leading to treatment cessation.", "population_specificity": "44 patients diagnosed with mesenteric vein thrombosis who underwent long-term anticoagulation therapy (median age 56 years, 52% male).", "effective_dosage": "Not specified", "study_duration": "Median duration of 13 months (20 months for vitamin K antagonists, 6 months for non-vitamin K antagonists).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:27.988505+00:00"}
{"study_id": 42161, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the safety and efficacy of vitamin K antagonists (VKAs) with direct oral anticoagulants (DOACs) in treating left ventricular thrombosis (LVT).", "results_summary": "DOACs, particularly rivaroxaban and apixaban, demonstrated faster resolution of LVT, lower mortality, and fewer complications (SSE and bleeding events) compared to VKAs.", "population_specificity": "Patients with left ventricular thrombosis (4213 participants across 32 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:28.685524+00:00"}
{"study_id": 42162, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether direct oral anticoagulants (DOACs), such as factor Xa inhibitors, could replace vitamin-K-antagonists (VKA) for anticoagulation in patients after mechanical aortic valve replacement.", "results_summary": "The study found that while VKA therapy remains the standard, factor Xa inhibitors like apixaban and rivaroxaban showed promising results in preventing thrombosis and thrombo-embolic events in comparable patient cohorts, though the PROACT-Xa study did not support apixaban's efficacy over VKA.", "population_specificity": "Patients after mechanical aortic valve replacement.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:30.158854+00:00"}
{"study_id": 42165, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the incidence of late bleeding events between patients on direct oral anticoagulants (DOACs) and those on vitamin-K antagonists (VKA) in atrial fibrillation patients undergoing TAVI.", "results_summary": "The study found that patients receiving DOACs had a higher risk of late bleeding events compared to those on VKA, with no significant differences in stroke, heart failure hospitalization, or all-cause mortality.", "population_specificity": "Older patients with atrial fibrillation undergoing transcatheter aortic valve implantation (TAVI).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 2.8 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:30.832818+00:00"}
{"study_id": 42163, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether the use of vitamin K antagonists (VKAs) modulates the risk of incident peripheral arterial disease (PAD) in people with type 2 diabetes.", "results_summary": "The study found no significant association between VKA use and overall PAD risk but observed a significantly increased risk of lower-limb amputation (LLA) in VKA users, while no excess risk was noted for lower-limb revascularization.", "population_specificity": "1468 patients with type 2 diabetes in a French cohort (SURDIAGENE).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 7 years (2002-2015).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:31.353962+00:00"}
{"study_id": 42168, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to highlight the consequences of parental refusal of postnatal vitamin K prophylaxis due to language barriers and its role in preventing hemorrhagic disease in newborns.", "results_summary": "The study found that refusal of vitamin K administration due to miscommunication (language barrier) led to severe intracranial hemorrhage in a newborn, which was successfully treated. Effective communication required a combination of a Spanish medical translator and a family friend.", "population_specificity": "Newborns (specifically one case involving a family speaking a rare Spanish dialect).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:35.763494+00:00"}
{"study_id": 42169, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review key messages and propose decision algorithms for managing patients with acute coronary syndrome treated with vitamin K antagonists or non-vitamin K antagonist oral anticoagulants.", "results_summary": "The study highlights the complexity of managing these patients and recommends specific heparin use during percutaneous coronary intervention. It notes a lack of randomized studies and proposes two decision algorithms, calling for further validation.", "population_specificity": "Patients with acute coronary syndrome treated with vitamin K antagonists or non-vitamin K antagonist oral anticoagulants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:36.743625+00:00"}
{"study_id": 42167, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the association of genetic variants (CYP2C9, CYP4F2, GGCX, VKORC1) with major bleeding risk in patients using vitamin K antagonists (VKAs).", "results_summary": "CYP4F2-TT carriership was associated with a non-significant 1.6-fold increased risk of major bleeding, while combined variant genotypes (CYP2C9, CYP4F2-TT, VKORC1-AA) showed a 4.0-fold increased risk. The highest risk (6.7-fold) was observed in carriers of both CYP4F2-TT and VKORC1-AA.", "population_specificity": "16,570 patients who initiated VKAs between 2012 and 2014, with 326 major bleeding cases and a subcohort of 978 patients.", "effective_dosage": "Not specified", "study_duration": "17,613 years of follow-up (aggregate)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:38.416141+00:00"}
{"study_id": 42172, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review current research on the impact of warfarin treatment on vascular calcification and identify potential molecular targets, including microRNA, in the implicated pathways.", "results_summary": "The abstract does not provide specific results regarding Vitamin K's effects but highlights that warfarin therapy has been shown to cause vascular calcification in arterial walls, though the exact mechanisms remain unclear.", "population_specificity": "Not specified (review of in vivo and in vitro models)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:39.097165+00:00"}
{"study_id": 42170, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to provide clinical practice suggestions for managing warfarin (a vitamin K antagonist) therapy, addressing initiation, subtherapeutic INR, supratherapeutic INR, and drug interactions.", "results_summary": "The study offers experience-based guidelines for warfarin management but does not present new efficacy data on vitamin K itself. It highlights challenges in warfarin's pharmacokinetics and patient risk factors.", "population_specificity": "Patients in Italy on anticoagulant therapies, particularly those prescribed warfarin.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Warfarin's interactions with other drugs are mentioned as a key management issue.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:39.099800+00:00"}
{"study_id": 42171, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 45, "study_goal": "The researchers aimed to demonstrate the rapid onset of coagulation dysfunction due to Vitamin K deficiency and its correction through supplementation in an elderly surgical patient.", "results_summary": "Vitamin K supplementation corrected severe coagulation dysfunction within a day in an elderly patient with gallstones and cholecystitis, preventing serious consequences. The deficiency was linked to long-term antibiotic use, poor diet, and liver dysfunction.", "population_specificity": "84-year-old male with gallstones, cholecystitis, and severe coagulation disorder post-endoscopic procedure.", "effective_dosage": "Not specified", "study_duration": "1 day (correction observed the next day)", "interactions": "Long-term cephalosporin anti-inflammatory therapy noted as a contributing factor to Vitamin K deficiency.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:39.523255+00:00"}
{"study_id": 42164, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of PIVKA-II (a biomarker linked to vitamin K absence) as a prognostic tool in liver transplantation for hepatocellular carcinoma (HCC).", "results_summary": "The study highlights PIVKA-II as a significant biomarker for HCC, particularly in liver transplantation contexts, but does not establish direct therapeutic effects of vitamin K itself. The abstract suggests PIVKA-II's potential in improving patient prognosis and survival but does not provide conclusive efficacy data on vitamin K supplementation.", "population_specificity": "Patients with hepatocellular carcinoma (HCC) undergoing liver transplantation.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:41.636129+00:00"}
{"study_id": 42174, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to compare the safety and efficacy of FXa inhibitors versus vitamin K antagonists (VKAs) in preventing major bleeding events and ischemic endpoints during the early phase after acute ischemic stroke or TIA.", "results_summary": "FXa inhibitors showed a lower rate of major bleeding events (14.7 vs. 20.7 per 10,000 treatment days) compared to VKAs, though the difference was not statistically significant. Both groups had similar risks for ischemic endpoints, mortality, and combined adverse events.", "population_specificity": "Patients with acute ischemic stroke or transient ischemic attack (TIA) treated at 86 German stroke units.", "effective_dosage": "Not specified", "study_duration": "Hospital stay (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:46.096515+00:00"}
{"study_id": 42175, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 30, "study_goal": "The researchers aimed to investigate cases of complete resistance to vitamin K antagonists in patients with specific VKORC1 gene mutations and explore optimal treatment strategies.", "results_summary": "The study found two patients with VKORC1 gene mutations (5417 GG genotype) who showed complete resistance to vitamin K antagonists, requiring a change in treatment with favorable outcomes. The cases highlight the challenges in managing such resistance when direct oral anticoagulants are not an option.", "population_specificity": "Two women in their fifties with unexplained peripheral venous thrombosis and specific VKORC1 gene mutations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Vitamin K antagonists (complete resistance noted)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:46.901824+00:00"}
{"study_id": 42176, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if accounting for competing risks of death affects the estimated benefit of vitamin K antagonists (VKAs) in preventing stroke or systemic embolism in atrial fibrillation patients.", "results_summary": "VKAs were highly effective at reducing stroke risk, but the CHA2DS2-VASc model overestimated their benefit by not accounting for competing risks of death, particularly in patients with lower life expectancies. The competing risk model showed a more accurate, though still significant, benefit.", "population_specificity": "Patients with atrial fibrillation (median age 73, 36% women, median life expectancy 8 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:47.774785+00:00"}
{"study_id": 42177, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to compare the perioperative and long-term outcomes of patients with peripheral arterial disease (PAD) undergoing peripheral vascular intervention (PVI) who were chronically anticoagulated with Factor Xa inhibitors (FXaI) versus vitamin K antagonists (VKA).", "results_summary": "The study found that VKA use was associated with higher rates of perioperative hematoma, major amputation, and mortality compared to FXaI. Patients on FXaI had improved amputation-free survival and lower adverse outcomes.", "population_specificity": "Patients with PAD undergoing PVI who required chronic anticoagulation.", "effective_dosage": "Not specified", "study_duration": "Long-term follow-up (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:47.911429+00:00"}
{"study_id": 43747, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Vitamins E and C, individually and combined, on oxidative stress, immune response, and mortality in chickens infected with the virulent Newcastle disease virus (NDV).", "results_summary": "Individual supplementation with Vitamin E or C was more effective than combined supplementation in reducing oxidative stress, improving immune response, and lowering mortality in NDV-infected chickens. Combined supplementation showed higher mortality rates (26.6%) compared to individual supplementation (3.3%).", "population_specificity": "Broiler chickens infected with the virulent NDV (KUDU 113 strain).", "effective_dosage": "Vitamin E (33 mg/kg/day) and Vitamin C (400 mg/kg/day).", "study_duration": "Supplementation began 7 days before virus challenge and continued post-infection, with analyses up to 21 days post-infection.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:49.859929+00:00"}
{"study_id": 43748, "supplement_id": 1666, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of vitamins E and C on reducing oxidative stress and improving blood parameters in power plant employees exposed to electromagnetic fields.", "results_summary": "The study found that vitamins E and C significantly increased antioxidant enzyme levels (SOD, Cat, TAC) and improved hematological parameters (RBC, hematocrit, MCH), while reducing lipid peroxidation (MDA). The effects were more pronounced in the vitamin E group compared to the control group.", "population_specificity": "Employees working in a power plant in Semnan, Iran.", "effective_dosage": "Vitamin E (400 units/day), vitamin C (1000 mg/day), or a combination for 90 days.", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:50.749332+00:00"}
{"study_id": 42173, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether direct oral anticoagulants (DOAC) and vitamin K antagonists (VKA) increase the risk of postoperative bleeding after dentoalveolar surgery.", "results_summary": "The study found no significant increase in postoperative bleeding risk for patients taking DOAC or VKA compared to non-anticoagulated controls, with bleeding rates of 2.9%, 4.8%, and 0.97% in the DOAC, VKA, and control groups, respectively. The adjusted odds ratios for bleeding were not statistically significant, suggesting dentoalveolar surgery can be performed safely without stopping these medications.", "population_specificity": "Patients undergoing dentoalveolar surgery, including those taking DOAC or VKA and non-anticoagulated controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:53.273036+00:00"}
{"study_id": 42166, "supplement_id": 1665, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess the appropriateness of prescribing profiles and intake adherence to non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation (AF).", "results_summary": "Dabigatran had the lowest percentage of guideline-consistent doses compared to other NOACs. Patients younger than 75 years with GFR >60 mL/min had the highest percentage of adequate GFR range, while other groups requiring closer GFR monitoring had lower percentages. Adherence to NOACs varied, with edoxaban showing the highest adherence and apixaban the lowest.", "population_specificity": "21,854 patients with atrial fibrillation prescribed NOACs between January 2016 and December 2018 in Northern Portugal.", "effective_dosage": "Not specified", "study_duration": "Retrospective data from January 2016 to December 2018", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:53.481053+00:00"}
{"study_id": 43749, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if vitamins E and C could prevent the negative reproductive effects of mancozeb exposure in first-generation mice pups.", "results_summary": "Vitamins E and C significantly improved oocyte maturation, fertilization rate, embryo development, and implantation rates compared to the mancozeb-exposed group, demonstrating a protective effect against reproductive toxicity.", "population_specificity": "First-generation mice pups exposed to mancozeb during gestation and lactation.", "effective_dosage": "Vitamin E (200 mg/kg BW), Vitamin C (100 mg/kg BW), administered 30 min before mancozeb exposure every 2 days.", "study_duration": "From the second day of gestation until the end of lactation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:55.345893+00:00"}
{"study_id": 43750, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the preventive effect of vitamins E and C on mancozeb-induced apoptosis in testicular and ovarian tissues of first-generation pups.", "results_summary": "Vitamins E and C, both alone and combined, significantly prevented mancozeb-induced apoptosis, with combined administration showing greater efficacy in ovarian tissue and vitamin C being more effective in testicular tissue.", "population_specificity": "Pregnant NMRI mice and their first-generation pups.", "effective_dosage": "200 mg/kg vitamin E and 100 mg/kg vitamin C, administered every 2 days.", "study_duration": "From the second day of gestation until weaning.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:55.954956+00:00"}
{"study_id": 43751, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effect of combined Vitamins E and C on colistin-induced tubular damage in rats.", "results_summary": "The study found that co-treatment with Vitamins E and C restored biochemical parameters (NAG, GGT, MDA, SOD, CAT, GPx) and improved histopathological damage caused by colistin, suggesting a nephroprotective effect mediated by antioxidant properties. The combination showed synergistic effects.", "population_specificity": "Rats with colistin-induced tubular damage", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:57.206293+00:00"}
{"study_id": 43752, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of vitamins E and C on yolk fatty acid profiles, cholesterol, triglyceride, and \u03b1-tocopherol concentrations, as well as the oxidation status of serum and yolk in laying hens.", "results_summary": "Vitamin E increased C16:0, C18:0, and C16:1 concentrations but decreased C18:2 and C22:6n3 in yolk, while vitamin C increased C18:0 and C18:3 and decreased the n6 to n3 ratio. Both vitamins reduced serum malondialdehyde (MDA) levels, indicating reduced oxidation.", "population_specificity": "W36 Hy-line laying hens (44 to 56 weeks old)", "effective_dosage": "250 mg/kg of vitamin E and 250 mg/kg of vitamin C", "study_duration": "84 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:57.883158+00:00"}
{"study_id": 43753, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of vitamins E and C, combined with \u03b2-carotene, on cognitive function in elderly subjects.", "results_summary": "The study found that vitamins E and C combined with \u03b2-carotene significantly improved cognitive function in elderly subjects, particularly with higher doses of \u03b2-carotene, and reduced plasma amyloid-\u03b2 levels while elevating estradiol levels.", "population_specificity": "Elderly subjects (276 participants)", "effective_dosage": "Different doses of \u03b2-carotene (specific amounts not mentioned)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:58.806027+00:00"}
{"study_id": 43754, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether chronic consumption of a high-fat diet (HFD) combined with antioxidants (vitamins C and E and astaxanthin) affects passive avoidance learning (PAL) in male rats.", "results_summary": "The study found that HFD impaired PAL, while antioxidant supplementation (including vitamins C and E) improved PAL deficits in the HFD group, increasing step-through latency and reducing time spent in the dark compartment. Restricted HFD with or without antioxidants showed no significant effect compared to the control group.", "population_specificity": "Male Wistar rats (N=6-8 per group).", "effective_dosage": "Not specified.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:42:59.569396+00:00"}
{"study_id": 43755, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To determine if combining carvedilol with vitamins E and C enhances their antioxidant effect in reducing oxidative stress in chronic Chagas heart disease patients.", "results_summary": "The combination of carvedilol with vitamins E and C significantly reduced oxidative stress markers, particularly protein damage and glutathione levels, and showed greater efficacy than carvedilol alone, suggesting potential synergism.", "population_specificity": "42 patients with Chagas heart disease, categorized by severity of cardiac involvement.", "effective_dosage": "Not specified", "study_duration": "Six months of combined therapy after six months of carvedilol alone.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:02.128505+00:00"}
{"study_id": 43756, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to assess whether early treatment of obstructive sleep apnea (OSA) combined with high-dose vitamins C and E, among other supplements, could improve neurological outcomes in a patient with adult-onset Leigh disease.", "results_summary": "The study reported marked clinical recovery in neurological symptoms and OSA after treatment with high-dose vitamins C and E, thiamine, coenzyme Q, and L-carnitine, alongside continuous positive airway pressure therapy. The improvement was observed in both clinical symptoms and brain MRI features.", "population_specificity": "A single adult patient with adult-onset Leigh disease presenting as severe brainstem encephalopathy.", "effective_dosage": "High doses (specific amounts not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:02.839145+00:00"}
{"study_id": 43758, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of vitamins E and C against endosulfan-induced reproductive toxicity in rats.", "results_summary": "Vitamins E and C reduced the toxic effects of endosulfan on sperm parameters and lipid peroxidation in the testis, with vitamin E showing superior protective effects compared to vitamin C.", "population_specificity": "Adult male Sprague-Dawley rats", "effective_dosage": "Vitamin C (20 mg/kg/day), vitamin E (200 mg/kg/day), or both at the same doses", "study_duration": "10 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:04.241553+00:00"}
{"study_id": 43757, "supplement_id": 1666, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine whether antioxidant therapy with vitamins C and E could improve oxidative stress markers and liver histology in patients with nonalcoholic steatohepatitis (NASH).", "results_summary": "The study found significant reductions in serum alanine aminotransferase, thioredoxin, and high-sensitivity C-reactive protein levels after 12 months of treatment. Liver biopsies also showed improved necroinflammatory activity in most cases and fibrosis staging in some.", "population_specificity": "Patients with nonalcoholic steatohepatitis (NASH).", "effective_dosage": "Vitamin E 300 mg/day and vitamin C 300 mg/day, administered orally.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:04.252682+00:00"}
{"study_id": 43759, "supplement_id": 1666, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "To determine whether alternate-day vitamin E or daily vitamin C supplementation affects the incidence of age-related macular degeneration (AMD) in male physicians.", "results_summary": "The study found no appreciable beneficial or harmful effect of vitamin E (400 IU alternate-day) or vitamin C (500 mg daily) on the risk of incident AMD diagnosis after 8 years. Hazard ratios for both vitamins were close to 1, indicating no significant impact.", "population_specificity": "14,236 apparently healthy U.S. male physicians aged \u226550 years without AMD at baseline.", "effective_dosage": "400 IU vitamin E (alternate-day), 500 mg vitamin C (daily).", "study_duration": "8 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:07.037140+00:00"}
{"study_id": 43761, "supplement_id": 1666, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "To determine whether alternate-day vitamin E or daily vitamin C supplementation affects the incidence of age-related cataract in healthy older men.", "results_summary": "The study found no notable beneficial or harmful effect of vitamin E (400 IU alternate-day) or vitamin C (500 mg daily) on cataract risk after 8 years, with hazard ratios close to 1.0 for both supplements.", "population_specificity": "11,545 apparently healthy US male physicians aged 50 or older without baseline cataract diagnosis.", "effective_dosage": "400 IU vitamin E (alternate days), 500 mg vitamin C (daily)", "study_duration": "8 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:07.187212+00:00"}
{"study_id": 43762, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether supplemental arginine, vitamin E, and vitamin C improved pulmonary vascular performance and reduced oxidative stress in hypoxic broiler chickens.", "results_summary": "Supplemental arginine improved pulmonary vascular recovery after epinephrine challenges, with further enhancement from added vitamin E and vitamin C. However, these supplements did not reduce ascites incidence in hypoxic conditions.", "population_specificity": "Broiler chicks housed in hypobaric chambers simulating 3,000 m above sea level.", "effective_dosage": "200 IU of vitamin E/kg of feed and 500 mg of vitamin C/L of water.", "study_duration": "From day 28 to 42 (14 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:08.271129+00:00"}
{"study_id": 43760, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether an anti-inflammatory dietary mixture (AIDM) containing vitamins E and C, among other components, could reduce inflammatory risk factors, proatherogenic lipids, and atherosclerosis in transgenic mouse models.", "results_summary": "The AIDM, including vitamins E and C, significantly reduced inflammatory markers (CRP, fibrinogen) and proatherogenic lipids (cholesterol, TG) and markedly decreased atherosclerotic lesion development by 96% in ApoE*3Leiden mice.", "population_specificity": "Male human CRP transgenic mice (inflammation model) and female ApoE*3Leiden transgenic mice (atherosclerosis model).", "effective_dosage": "0.567% (wt:wt) powder (containing vitamins E and C) and 0.933% (wt:wt) oil.", "study_duration": "6 weeks (inflammation study) and 16 weeks (atherosclerosis study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:08.842605+00:00"}
{"study_id": 43764, "supplement_id": 1666, "safety_score": "85", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to determine whether long-term supplementation with vitamins E or C reduces the risk of prostate and total cancer in men.", "results_summary": "The study found no significant effect of vitamin E or C on the incidence of prostate cancer or total cancer. Neither supplement showed benefits for colorectal, lung, or other site-specific cancers.", "population_specificity": "14,641 male physicians in the U.S., initially aged 50 years or older, including 1,307 men with prior cancer history.", "effective_dosage": "400 IU of vitamin E every other day and 500 mg of vitamin C daily.", "study_duration": "Mean follow-up of 8.0 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:12.028532+00:00"}
{"study_id": 43765, "supplement_id": 1666, "safety_score": "70", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to determine whether long-term supplementation with vitamin E or vitamin C reduces the risk of major cardiovascular events in men.", "results_summary": "The study found no significant effect of either vitamin E or vitamin C on major cardiovascular events, myocardial infarction, stroke, or cardiovascular mortality. Vitamin E was associated with an increased risk of hemorrhagic stroke.", "population_specificity": "14,641 US male physicians aged 50 years or older, including 5.1% with prevalent cardiovascular disease at randomization.", "effective_dosage": "400 IU of vitamin E every other day and 500 mg of vitamin C daily.", "study_duration": "Mean follow-up of 8 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:13.284075+00:00"}
{"study_id": 43766, "supplement_id": 1666, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of short-term antioxidant therapy (vitamins C and E) on oxidative stress markers in STZ-induced diabetic rats.", "results_summary": "Vitamins C and E reduced oxidative stress markers (plasma lactic acid, thiobarbituric acid reacting substances, urine 8-isoprostane) and improved some complications of diabetes, though effects on plasma alpha-tocopherol/lipids ratio were only observed in control rats.", "population_specificity": "Adult female rats with STZ-induced diabetes.", "effective_dosage": "5 doses over 3 days (exact amounts not specified).", "study_duration": "3 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:13.476377+00:00"}
{"study_id": 43763, "supplement_id": 1666, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of vitamins E and C supplementation on liver function and lipid profiles in male rats with CCl4-induced liver damage when combined with different dietary oils.", "results_summary": "Vitamins E and C supplementation significantly improved lipid profiles (reduced TC and LDL-C, increased HDL-C) and liver enzyme levels (reduced ALT) in rats, with the most pronounced effects observed in the flaxseed oil group. Histological results showed near-normal hepatocytes in groups receiving supplemented flaxseed or olive oil.", "population_specificity": "Male rats with CCl4-induced chronic liver damage", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:17.413282+00:00"}
{"study_id": 90193, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not address the safety, efficacy, or quality of Walking.", "results_summary": "The abstract does not provide any findings related to Walking.", "population_specificity": "Not specified (abstract focuses on onychomycosis, not Walking).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:24.976468+00:00"}
{"study_id": 90197, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of robot-assisted gait training on walking capacity after stroke and to explain the heterogeneity of results in previous meta-analyses.", "results_summary": "The study found that robot-assisted gait training combined with physiotherapy and body-weight support significantly improved gait speed, Functional Ambulation Classification scores, and Berg Balance Scale scores compared to physiotherapy alone. The results were underestimated due to attrition bias in the included studies.", "population_specificity": "Adult patients with stroke.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:25.313187+00:00"}
{"study_id": 90196, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether leucine supplementation could improve muscle mass, strength, functional performance (including walking time), and respiratory muscle function in institutionalized older individuals with sarcopenia.", "results_summary": "Leucine administration significantly improved some sarcopenia criteria, such as functional performance measured by walking time, and was well-tolerated. The study did not report adverse effects related to walking.", "population_specificity": "Institutionalized older individuals aged 65 and over with sarcopenia.", "effective_dosage": "6 g/day of leucine or placebo (lactose).", "study_duration": "13 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:25.851002+00:00"}
{"study_id": 90198, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether gait quality (symmetry and natural patterns) improves alongside gait function (speed) during early recovery in subacute stroke patients.", "results_summary": "The study found that overall gait symmetry improved with walking speed, but limb and joint kinematic parameters remained asymmetric even at maximum recovery levels. Limb kinematic parameters showed specific patterns of asymmetry despite functional improvements.", "population_specificity": "Six individuals with subacute stroke (<1 month post-stroke).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:26.388963+00:00"}
{"study_id": 90194, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 55, "quality_score": 70, "study_goal": "The researchers aimed to compare the effect of post-meal walking versus one prandial insulin on glycemic control in type 2 diabetic patients who failed basal insulin therapy.", "results_summary": "Post-meal walking showed a modest reduction in HbA1c and fructosamine levels, comparable to prandial insulin, but the differences were not statistically significant. The magnitude of glycemic improvement was small, suggesting similar but limited efficacy between the two interventions.", "population_specificity": "Type 2 diabetic patients who failed basal insulin therapy.", "effective_dosage": "15-20 minutes of walking after one meal per day.", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:26.468155+00:00"}
{"study_id": 90191, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to describe frailty status transition rates over 2 years in stable COPD patients and identify predictors of improvement in frailty status, including factors like walking speed.", "results_summary": "Over 2 years, 17.6% of patients improved in frailty status, 11.7% worsened, and 70.5% remained stable. Improved frailty was associated with greater handgrip and quadriceps strength, physical activity, and lower disability, while worsening was linked to greater dyspnea and disability.", "population_specificity": "119 stable COPD patients (mean age 66.9 \u00b1 7.9 years).", "effective_dosage": "Not specified", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:26.747014+00:00"}
{"study_id": 90192, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine racial differences in mobility limitation (difficulty walking or climbing stairs) among prostate cancer survivors and assess the role of socioeconomic status in these differences.", "results_summary": "Black prostate cancer survivors initially showed higher mobility limitations than White survivors, but this difference disappeared after accounting for socioeconomic factors like education and income. The study highlights SES as a key factor in racial disparities in mobility.", "population_specificity": "661 prostate cancer survivors (296 Black, 365 White) from the DAD Study.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:26.859263+00:00"}
{"study_id": 90199, "supplement_id": 1667, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether controlled maternal physical exercise (walking) at term enhances spontaneous labor onset and reduces labor induction rates in low-risk pregnant women.", "results_summary": "The study found that walking reduced labor induction rates (17.5% vs. 33.3%) and operative vaginal deliveries (20.6% vs. 38.1%) compared to the control group, with no adverse maternal or fetal effects. No differences were observed in gestational age at labor onset, cesarean rates, or birth outcomes.", "population_specificity": "Low-risk pregnant women at 38 weeks with a singleton cephalic fetus and no prior cesarean deliveries.", "effective_dosage": "30 minutes of walking at 4 km/h, 3 times per week.", "study_duration": "From 38 weeks of gestation until labor onset.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:27.443144+00:00"}
{"study_id": 90202, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of different physical training programs (aerobic, resistance, or combined) with or without counseling/diet modifications on physical fitness in individuals with class II and III obesity.", "results_summary": "The meta-analysis showed improvements in walking speed and maximal oxygen uptake but not knee extension strength in the intervention groups. A combination of aerobic and resistance exercise, along with diet modifications, may improve cardiovascular and muscular endurance in this population, though results were limited by study heterogeneity.", "population_specificity": "Individuals with class II and III obesity (BMI \u226535 kg/m\u00b2) aged 18 years or older.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:34.619357+00:00"}
{"study_id": 90200, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of closed reduction with crossed Kirschner wire fixation for treating displaced supracondylar femoral fractures in young children.", "results_summary": "All patients achieved fracture healing within 10 weeks, resumed walking between 10 to 13 weeks, and had perfect Knee Society Scores with no significant complications like valgus deformity, neurovascular injury, or infection.", "population_specificity": "Young children (average age 2.5 years) with displaced supracondylar femoral fractures.", "effective_dosage": "Not applicable (surgical intervention).", "study_duration": "Follow-up averaged 26 months (range 24-30).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:35.330124+00:00"}
{"study_id": 90201, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy of r-ESWT versus sham-ESWT on pain, walking speed, physical function, and muscle strength in knee osteoarthritis patients.", "results_summary": "The r-ESWT group showed significantly better improvements in pain, walking speed, physical function, and muscle strength compared to the sham-ESWT group, with benefits sustained up to three months post-treatment.", "population_specificity": "104 patients (mean age 61.0 \u00b1 6.2 years; range 50-70 years) with newly diagnosed knee osteoarthritis.", "effective_dosage": "2000 pulses of shockwave at 2.0-3.0 bar weekly for three weeks.", "study_duration": "Three weeks of intervention, with follow-ups at one and three months post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:43:35.671048+00:00"}
